Thrombopoietin	B-protein
supports	O
in	O
vitro	O
erythroid	O
differentiation	O
via	O
its	O
specific	O
receptor	O
c-Mpl	B-protein
in	O
a	O
human	B-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

Thrombopoietin	B-protein
(	O
TPO	B-protein
)	O
acts	O
on	O
megakaryopoiesis	O
and	O
erythropoiesis	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

We	O
isolated	O
a	O
novel	O
subline	O
,	O
UT-7/GMT	B-cell_line
,	O
from	O
the	O
human	B-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
UT-7/GM	I-cell_line
(	O
N.	O
Komatsu	O
,	O
et	O
al.	O
,	O
Blood	O
,	O
89	O
:	O
4021-4033	O
,	O
1997	O
)	O
.	O

A	O
small	O
population	O
of	O
UT-7/GM	B-cell_line
cells	I-cell_line
positively	O
stained	O
for	O
hemoglobin	B-protein
(	O
Hb	B-protein
)	O
after	O
a	O
7-day	O
exposure	O
to	O
TPO	B-protein
.	O

More	O
than	O
50	O
%	O
of	O
TPO-treated	B-cell_line
UT-7/GMT	I-cell_line
cells	I-cell_line
positively	O
stained	O
for	O
Hb	B-protein
.	O

Using	O
UT-7/GMT	B-cell_line
cells	I-cell_line
,	O
we	O
examined	O
how	O
TPO	B-protein
promotes	O
hemoglobinization	O
.	O

TPO	B-protein
induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
TPO	B-protein
receptor	O
but	O
not	O
the	O
erythropoietin	B-protein
(	I-protein
EPO	I-protein
)	I-protein
receptor	I-protein
.	O

There	O
was	O
no	O
competition	O
between	O
TPO	B-protein
and	O
EPO	B-protein
for	O
binding	O
to	O
EPO	B-protein
receptor	I-protein
.	O

These	O
findings	O
suggest	O
that	O
TPO	B-protein
has	O
a	O
direct	O
effect	O
on	O
hemoglobinization	O
via	O
a	O
specific	O
receptor	O
on	O
UT-7/GMT	B-cell_line
cells	I-cell_line
.	O

Isoelectric	O
focusing	O
demonstrated	O
that	O
TPO	B-protein
induced	O
fetal	O
and	O
adult	O
Hb	O
synthesis	O
,	O
whereas	O
EPO	B-protein
induced	O
embryonic	O
,	O
fetal	O
,	O
and	O
adult	O
Hb	O
synthesis	O
.	O

Thus	O
,	O
our	O
data	O
suggest	O
that	O
TPO	B-protein
has	O
a	O
distinct	O
action	O
on	O
erythropoiesis	O
.	O

Vol	NULL
.	NULL

9	NULL
,	NULL
487-496	NULL
,	NULL
June	NULL
1998	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Thrombopoietin	NULL
Supports	NULL
in	NULL
Vitro	NULL
Erythroid	NULL
Differentiation	NULL
via	NULL
Its	NULL
Specific	NULL
Receptor	NULL
c-Mpl	NULL
in	NULL
a	NULL
Human	NULL
Leukemia	NULL
Cell	NULL
Line	NULL
'	NULL
Minami	NULL
Yamada	NULL
,	NULL
Norio	NULL
Komatsu	NULL
,	NULL
``	NULL
Keita	NULL
Kirito	NULL
,	NULL
Yoshifumi	NULL
Kashii	NULL
,	NULL
Hiroshi	NULL
Tomizuka	NULL
,	NULL
Koji	NULL
Okada	NULL
,	NULL
Toshiyasu	NULL
Endo	NULL
,	NULL
Yasuyuki	NULL
Fukumaki	NULL
,	NULL
Kaori	NULL
Shinjo	NULL
,	NULL
Keishi	NULL
Abe	NULL
,	NULL
and	NULL
Yasusada	NULL
Miura	NULL
Divisions	NULL
of	NULL
Hematology	NULL
[	NULL
M.	NULL
Y.	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Y.	NULL
K.	NULL
,	NULL
H.	NULL
T.	NULL
,	NULL
Y.	NULL
M.	NULL
}	NULL
,	NULL
Endocrinology	NULL
[	NULL
K	NULL
.	NULL

O	NULL
.	NULL
]	NULL

,	NULL
and	NULL
Metabolism	NULL
[	NULL
K	NULL
.	NULL

O	NULL
.	NULL
]	NULL

,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Tochigi	NULL
329-04	NULL
,	NULL
Japan	NULL
;	NULL
Department	NULL
of	NULL
School-Nurse	NULL
Training	NULL
,	NULL
Kyushu	NULL
Women	NULL
's	NULL
Junior	NULL
College	NULL
[	NULL
T.	NULL
E.	NULL
]	NULL
,	NULL
and	NULL
The	NULL
Research	NULL
Laboratory	NULL
for	NULL
Genetic	NULL
Information	NULL
[	NULL
Y.	NULL
F.	NULL
]	NULL
,	NULL
Kyushu	NULL
University	NULL
,	NULL
Fukuoka	NULL
;	NULL
and	NULL
Third	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Hamamatsu	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
[	NULL
K.	NULL
S.	NULL
]	NULL
,	NULL
and	NULL
Second	NULL
Division	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
[	NULL
M.	NULL
Y.	NULL
,	NULL
K	NULL
.	NULL

A	NULL
.	NULL
]	NULL

,	NULL
Sendai	NULL
,	NULL
Japan	NULL
Abstract	NULL
Thrombopoietin	NULL
(	NULL
TPO	NULL
)	NULL
acts	NULL
on	NULL
megakaryopoiesis	NULL
and	NULL
erythropoiesis	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
isolated	NULL
a	NULL
novel	NULL
subline	NULL
,	NULL
UT-7/GMT	NULL
,	NULL
from	NULL
the	NULL
human	NULL
leukemia	NULL
cell	NULL
line	NULL
UT-7/GM	NULL
(	NULL
N.	NULL
Komatsu	NULL
,	NULL
et	NULL
al	NULL
.	NULL

,	NULL
Blood	NULL
,	NULL
89	NULL
:	NULL
4021-4033	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

A	NULL
small	NULL
population	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
positively	NULL
stained	NULL
for	NULL
hemoglobin	NULL
(	NULL
Hb	NULL
)	NULL
after	NULL
a	NULL
7-day	NULL
exposure	NULL
to	NULL
TPO	NULL
.	NULL

More	NULL
than	NULL
50	NULL
%	NULL
of	NULL
TPO-treated	NULL
UT-7/GMT	NULL
cells	NULL
positively	NULL
stained	NULL
for	NULL
Hb	NULL
.	NULL

Using	NULL
UT-7/GMT	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
how	NULL
TPO	NULL
promotes	NULL
hemoglobinization	NULL
.	NULL

TPO	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
TPO	NULL
receptor	NULL
but	NULL
not	NULL
the	NULL
erythropoietin	NULL
(	NULL
EPO	NULL
)	NULL
receptor	NULL
.	NULL

There	NULL
was	NULL
no	NULL
competition	NULL
between	NULL
TPO	NULL
and	NULL
EPO	NULL
for	NULL
binding	NULL
to	NULL
EPO	NULL
receptor	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
TPO	NULL
has	NULL
a	NULL
direct	NULL
effect	NULL
on	NULL
hemogliobinization	NULL
via	NULL
a	NULL
specific	NULL
receptor	NULL
on	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

Isoelectric	NULL
focusing	NULL
demonstrated	NULL
that	NULL
TPO	NULL
induced	NULL
fetal	NULL
and	NULL
adult	NULL
Hb	NULL
synthesis	NULL
,	NULL
whereas	NULL
EPO	NULL
induced	NULL
embryonic	NULL
,	NULL
fetal	NULL
,	NULL
and	NULL
adult	NULL
Hb	NULL
synthesis	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
TPO	NULL
has	NULL
a	NULL
distinct	NULL
action	NULL
on	NULL
erythropoiesis	NULL
.	NULL

Introduction	NULL
TPO	NULL
,	NULL
»	NULL
the	NULL
ligand	NULL
of	NULL
c-Mpl	NULL
,	NULL
regulates	NULL
the	NULL
growth	NULL
and	NULL
maturation	NULL
of	NULL
megakaryocytes	NULL
and	NULL
platelet	NULL
production	NULL
(	NULL
1	NULL
)	NULL
.	NULL

TPO	NULL
Received	NULL
2/2/98	NULL
;	NULL
revised	NULL
5/11/98	NULL
;	NULL
accepted	NULL
5/12/98	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants-in-Aid	NULL
for	NULL
Cancer	NULL
Research	NULL
and	NULL
Scientific	NULL
Research	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Yamanouchi	NULL
Foundation	NULL
for	NULL
Research	NULL
on	NULL
Metabolic	NULL
Disorders	NULL
.	NULL

?	NULL

To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
,	NULL
at	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Minami-kawachi-machi	NULL
,	NULL
Kawachi-gun	NULL
,	NULL
Tochigi-ken	NULL
329-04	NULL
,	NULL
Japan	NULL
.	NULL

Phone	NULL
:	NULL
81-285-44-2111	NULL
ext	NULL
.	NULL

3455	NULL
;	NULL
Fax	NULL
:	NULL
81-285-44-5258	NULL
;	NULL
E-mail	NULL
:	NULL
nkomatsu	NULL
@	NULL
ms.	NULL
jichi.ac.jp	NULL
.	NULL

°	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TPO	NULL
,	NULL
thrombopoietin	NULL
;	NULL
EPO	NULL
,	NULL
erythropoietin	NULL
;	NULL
EPOR	NULL
,	NULL
EPO	NULL
receptor	NULL
;	NULL
Hb	NULL
,	NULL
hemoglobin	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
MTT	NULL
,	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-y	NULL
(	NULL
)	NULL
-2,5-diphenyltetrazolium	NULL
bromide	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcriptase-PCR	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
;	NULL
ALAS-E	NULL
,	NULL
erythroid-specific	NULL
5-aminolevulinate	NULL
synthetase	NULL
;	NULL
NF-E2	NULL
,	NULL
nuclear	NULL
factor	NULL
E2	NULL
;	NULL
IEF	NULL
,	NULL
isoelectric	NULL
focusing	NULL
;	NULL
PF4	NULL
,	NULL
platelet	NULL
factor-4	NULL
;	NULL
GPllb	NULL
,	NULL
glyco-	NULL
has	NULL
two	NULL
major	NULL
domains	NULL
.	NULL

One	NULL
is	NULL
the	NULL
EPO	NULL
domain	NULL
,	NULL
which	NULL
has	NULL
significant	NULL
homology	NULL
with	NULL
EPO	NULL
,	NULL
the	NULL
key	NULL
regulator	NULL
of	NULL
erythro-poiesis	NULL
;	NULL
this	NULL
EPO	NULL
domain	NULL
is	NULL
sufficient	NULL
for	NULL
TPO	NULL
receptor	NULL
activation	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
other	NULL
is	NULL
a	NULL
unique	NULL
,	NULL
potentially	NULL
N-linked	NULL
glyco-sylation	NULL
domain	NULL
;	NULL
this	NULL
second	NULL
domain	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
EPO	NULL
3	NULL
'	NULL
noncoding	NULL
region	NULL
(	NULL
3	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
EPO	NULL
and	NULL
TPO	NULL
genes	NULL
evolved	NULL
from	NULL
a	NULL
common	NULL
ancestral	NULL
sequence	NULL
by	NULL
duplication	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
proliferation	NULL
and	NULL
maturation	NULL
of	NULL
megakaryocyte	NULL
and	NULL
erythroid	NULL
precursors	NULL
are	NULL
regulated	NULL
by	NULL
the	NULL
structurally	NULL
and	NULL
ontogenically	NULL
related	NULL
cytokines	NULL
TPO	NULL
and	NULL
EPO	NULL
,	NULL
respectively	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
found	NULL
that	NULL
TPO	NULL
has	NULL
erythroid	NULL
burst-promoting	NULL
activity	NULL
in	NULL
vitro	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
administration	NULL
of	NULL
TPO	NULL
to	NULL
myelosuppressed	NULL
mice	NULL
and	NULL
normal	NULL
mice	NULL
elevated	NULL
the	NULL
number	NULL
of	NULL
erythroid	NULL
and	NULL
megakaryocyte	NULL
progenitors	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
TPO	NULL
directly	NULL
acted	NULL
on	NULL
pure	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
expressing	NULL
CD41	NULL
and	NULL
the	NULL
TPO	NULL
receptor	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
reported	NULL
that	NULL
TPO	NULL
supports	NULL
not	NULL
only	NULL
proliferation	NULL
but	NULL
also	NULL
maturation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
in	NULL
vitro	NULL
in	NULL
mouse	NULL
embryos	NULL
lacking	NULL
the	NULL
EPOR	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
little	NULL
doubt	NULL
that	NULL
TPO	NULL
is	NULL
involved	NULL
in	NULL
erythropoiesis	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
TPO	NULL
induces	NULL
erythroid	NULL
differentiation	NULL
remains	NULL
unknown	NULL
.	NULL

To	NULL
further	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
TPO	NULL
in	NULL
erythropoiesis	NULL
,	NULL
we	NULL
isolated	NULL
a	NULL
novel	NULL
subline	NULL
,	NULL
UT-7/GMT	NULL
,	NULL
from	NULL
the	NULL
human	NULL
cytokine-dependent	NULL
cell	NULL
line	NULL
UT-7/GM	NULL
(	NULL
9	NULL
)	NULL
.	NULL

UT-7/GMT	NULL
can	NULL
differentiate	NULL
into	NULL
erythroid	NULL
cells	NULL
with	NULL
a	NULL
high	NULL
concentration	NULL
of	NULL
Hb	NULL
after	NULL
treatment	NULL
with	NULL
TPO	NULL
.	NULL

Using	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
TPO	NULL
induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Results	NULL
Establishment	NULL
of	NULL
the	NULL
UT-7/GMT	NULL
Cell	NULL
Line	NULL
.	NULL

UT-7/GM	NULL
is	NULL
a	NULL
bipotential	NULL
cell	NULL
line	NULL
that	NULL
can	NULL
differentiate	NULL
into	NULL
erythroid	NULL
or	NULL
megakaryocytic	NULL
lineages	NULL
with	NULL
EPO	NULL
or	NULL
TPO	NULL
,	NULL
respectively	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
evidence	NULL
that	NULL
a	NULL
minor	NULL
population	NULL
of	NULL
UT-7/GM	NULL
cells	NULL
differentiate	NULL
into	NULL
Hb-positive	NULL
cells	NULL
after	NULL
a	NULL
2-week	NULL
exposure	NULL
to	NULL
TPO	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
isolate	NULL
a	NULL
subline	NULL
that	NULL
definitely	NULL
differentiates	NULL
into	NULL
erythroid	NULL
cells	NULL
by	NULL
TPO	NULL
,	NULL
we	NULL
seeded	NULL
UT-7/GM	NULL
cells	NULL
onto	NULL
methylcellulose	NULL
semisolid	NULL
medium	NULL
and	NULL
randomly	NULL
picked	NULL
12	NULL
colonies	NULL
.	NULL

A	NULL
single	NULL
colony	NULL
was	NULL
transferred	NULL
to	NULL
liquid	NULL
culture	NULL
medium	NULL
containing	NULL
1	NULL
ng/ml	NULL
GM-CSF	NULL
.	NULL

Each	NULL
clone	NULL
was	NULL
then	NULL
expanded	NULL
,	NULL
washed	NULL
of	NULL
growth	NULL
factor	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
fresh	NULL
medium	NULL
containing	NULL
10	NULL
ng/m	NULL
!	NULL

TPO	NULL
.	NULL

Clones	NULL
contained	NULL
a	NULL
range	NULL
of	NULL
0-62.3	NULL
%	NULL
positive	NULL
dianisidine	NULL
staining	NULL
cells	NULL
after	NULL
TPO	NULL
treatment	NULL
.	NULL

In	NULL
the	NULL
following	NULL
experiments	NULL
,	NULL
we	NULL
used	NULL
clone	NULL
11	NULL
,	NULL
which	NULL
showed	NULL
the	NULL
highest	NULL
dianisidine	NULL
positivity	NULL
after	NULL
TPO	NULL
treatment	NULL
,	NULL
and	NULL
designated	NULL
this	NULL
clone	NULL
UT-7Z/GMT	NULL
.	NULL

protein	NULL
IIb	NULL
;	NULL
IMDM	NULL
,	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
;	NULL
PVDF	NULL
,	NULL
polyvi-nylidene	NULL
fluoride	NULL
;	NULL
b-EPO	NULL
,	NULL
biotin-labeled	NULL
EPO	NULL
.	NULL

488	NULL
-	NULL
Thrombopoietin	NULL
and	NULL
Erythropoiesis	NULL
Cell	NULL
Number	NULL
(	NULL
x10'/ml	NULL
)	NULL
o	NULL
MTT	NULL
reduction	NULL
(	NULL
0.D	NULL
.	NULL

595nm	NULL
)	NULL
Days	NULL
in	NULL
Culture	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
0	NULL
GM-CSF	NULL
0	NULL
0.01	NULL
-	NULL
0.1	NULL
1	NULL
10	NULL
ingimi	NULL
EPO	NULL
0	NULL
0.01	NULL
_	NULL
0.1	NULL
U	NULL
10	NULL
|	NULL
(	NULL
wint	NULL
)	NULL
TPO	NULL
0	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
(	NULL
ngimi	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Growth	NULL
profiles	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
in	NULL
suspension	NULL
culture	NULL
.	NULL

UT-7/GM	NULL
(	NULL
4	NULL
)	NULL
and	NULL
UT-7/GMT	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
tissue	NULL
culture	NULL
flasks	NULL
with	NULL
GM-CSF	NULL
{	NULL
1	NULL
ng/ml	NULL
;	NULL
@	NULL
)	NULL
,	NULL
EPO	NULL
(	NULL
1	NULL
unit/ml	NULL
;	NULL
©	NULL
)	NULL
,	NULL
or	NULL
TPO	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
®	NULL
)	NULL
or	NULL
without	NULL
cytokines	NULL
(	NULL
L	NULL
)	NULL
.	NULL

Data	NULL
points	NULL
,	NULL
numbers	NULL
of	NULL
viable	NULL
cells	NULL
,	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
.	NULL

C	NULL
,	NULL
proliferative	NULL
responses	NULL
of	NULL
UT-7/GMT	NULL
were	NULL
measured	NULL
by	NULL
MTT	NULL
assay	NULL
,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

as	NULL
®	NULL
o	NULL
507	NULL
25	NULL
Dianisidine	NULL
positive	NULL
cells	NULL
(	NULL
%	NULL
)	NULL
0	NULL
1	NULL
3	NULL
5	NULL
7	NULL
Days	NULL
in	NULL
Culture	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Increase	NULL
of	NULL
Hb	NULL
synthesis	NULL
by	NULL
EPO	NULL
and	NULL
TPO	NULL
and	NULL
suppression	NULL
by	NULL
GM-CSF	NULL
in	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

UT-7/GMT	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
{	NULL
1	NULL
ng/ml	NULL
}	NULL
;	NULL
®	NULL
)	NULL
,	NULL
EPO	NULL
(	NULL
1	NULL
unit/ml	NULL
;	NULL
or	NULL
TPO	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
©	NULL
)	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
stained	NULL
with	NULL
dianisidine	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Data	NULL
points	NULL
,	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
bars	NULL
,	NULL
SD	NULL
.	NULL

The	NULL
UT-7/GMT	NULL
cell	NULL
line	NULL
has	NULL
saturation	NULL
densities	NULL
of	NULL
1.2	NULL
%	NULL
105/ml	NULL
,	NULL
1.0	NULL
x	NULL
10°/ml	NULL
,	NULL
and	NULL
9	NULL
x	NULL
10°/ml	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
,	NULL
EPO	NULL
,	NULL
and	NULL
TPO	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
growth	NULL
activities	NULL
of	NULL
GM-CSF	NULL
,	NULL
EPO	NULL
,	NULL
and	NULL
TPO	NULL
toward	NULL
UT-7/GMT	NULL
cells	NULL
were	NULL
almost	NULL
the	NULL
same	NULL
as	NULL
those	NULL
from	NULL
a	NULL
MTT	NULL
assay	NULL
in	NULL
short-term	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

When	NULL
growth	NULL
factors	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
culture	NULL
,	NULL
however	NULL
,	NULL
the	NULL
cells	NULL
died	NULL
within	NULL
a	NULL
few	NULL
days	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
UT-7/GMT	NULL
also	NULL
had	NULL
absolute	NULL
dependency	NULL
on	NULL
these	NULL
cytokines	NULL
for	NULL
growth	NULL
and	NULL
survival	NULL
,	NULL
as	NULL
did	NULL
the	NULL
original	NULL
UT-7	NULL
and	NULL
UT-7/GM	NULL
.	NULL

We	NULL
found	NULL
that	NULL
80	NULL
,	NULL
50	NULL
,	NULL
and	NULL
0.3	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
dianisidine	NULL
staining	NULL
after	NULL
5-day	NULL
exposures	NULL
to	NULL
EPO	NULL
,	NULL
TPO	NULL
,	NULL
and	NULL
GM-CSF	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
the	NULL
morphological	NULL
characteristics	NULL
of	NULL
UT-7/	NULL
GMT	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
,	NULL
EPO	NULL
,	NULL
or	NULL
TPO	NULL
for	NULL
7	NULL
days	NULL
.	NULL

The	NULL
cytospin	NULL
smear	NULL
of	NULL
cells	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
contained	NULL
cells	NULL
with	NULL
a	NULL
prominent	NULL
nucleolus	NULL
and	NULL
cytoplasmic	NULL
blebs	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
EPO	NULL
or	NULL
TPO	NULL
,	NULL
the	NULL
cells	NULL
became	NULL
smaller	NULL
,	NULL
lost	NULL
their	NULL
cytoplasmic	NULL
vacuoles	NULL
and	NULL
blebs	NULL
,	NULL
and	NULL
showed	NULL
proerythroblast-like	NULL
morphology	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
morphological	NULL
analysis	NULL
revealed	NULL
that	NULL
UT-7/GMT	NULL
differentiated	NULL
to	NULL
erythroid	NULL
cells	NULL
with	NULL
TPO	NULL
or	NULL
EPO	NULL
treatment	NULL
.	NULL

This	NULL
was	NULL
confirmed	NULL
by	NULL
dianisidine	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
D-F	NULL
)	NULL
TPO	NULL
Transduces	NULL
Signals	NULL
via	NULL
c-Mpl	NULL
but	NULL
not	NULL
EPOR	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
TPO-induced	NULL
hemoglobinization	NULL
signal	NULL
was	NULL
transduced	NULL
by	NULL
EPOR	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
TPO	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
EPOR	NULL
.	NULL

EPOR	NULL
was	NULL
tyrosine-phosphorylated	NULL
by	NULL
EPO	NULL
but	NULL
not	NULL
by	NULL
TPO	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TPO	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
c-Mpl	NULL
but	NULL
not	NULL
of	NULL
EPOR	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Anti-c-Mp	NULL
!	NULL

antibodies	NULL
specifically	NULL
inhibited	NULL
TPO-	NULL
but	NULL
not	NULL
EPO-induced	NULL
proliferation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
could	NULL
not	NULL
examine	NULL
whether	NULL
or	NULL
not	NULL
these	NULL
anti-c-Mpl	NULL
antibodies	NULL
inhibited	NULL
TPO-induced	NULL
hemoglobinization	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
because	NULL
the	NULL
cells	NULL
died	NULL
within	NULL
a	NULL
few	NULL
days	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
these	NULL
antibodies	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
containing	NULL
TPO	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

RT-PCR	NULL
revealed	NULL
that	NULL
EPO	NULL
mRNA	NULL
was	NULL
undetectable	NULL
in	NULL
TPO-treated	NULL
UT-7/	NULL
GMT	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
EPO	NULL
activity	NULL
was	NULL
undetectable	NULL
by	NULL
RIA	NULL
in	NULL
conditioned	NULL
medium	NULL
from	NULL
TPO-treated	NULL
UT-7/GMT	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
TPO	NULL
transduces	NULL
its	NULL
signals	NULL
via	NULL
the	NULL
activation	NULL
of	NULL
its	NULL
specific	NULL
receptor	NULL
,	NULL
c-Mpl	NULL
.	NULL

There	NULL
Is	NULL
No	NULL
Competition	NULL
between	NULL
TPO	NULL
and	NULL
EPO	NULL
for	NULL
Binding	NULL
to	NULL
EPOR	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
competition	NULL
assay	NULL
between	NULL
EPO	NULL
and	NULL
TPO	NULL
for	NULL
binding	NULL
to	NULL
EPOR	NULL
.	NULL

The	NULL
number	NULL
of	NULL
EPO-binding	NULL
sites	NULL
per	NULL
cell	NULL
was	NULL
784	NULL
+	NULL
210	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
in	NULL
untreated	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

The	NULL
number	NULL
was	NULL
almost	NULL
unchanged	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
and	NULL
10	NULL
ng/m|	NULL
TPO	NULL
,	NULL
respectively	NULL
[	NULL
715	NULL
+	NULL
273	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
versus	NULL
701	NULL
+	NULL
59	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
]	NULL
.	NULL

Although	NULL
a	NULL
high	NULL
dose	NULL
of	NULL
TPO	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

reduced	NULL
the	NULL
number	NULL
of	NULL
EPO-binding	NULL
sites	NULL
[	NULL
511	NULL
+	NULL
150	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
]	NULL
,	NULL
there	NULL
was	NULL
no	NULL
statistical	NULL
significance	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
TPO	NULL
did	NULL
not	NULL
compete	NULL
with	NULL
binding	NULL
of	NULL
EPO	NULL
to	NULL
EPOR	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

TPO	NULL
Activated	NULL
the	NULL
JAK-STAT	NULL
Pathway	NULL
in	NULL
UT-7/GMT	NULL
.	NULL

Several	NULL
independent	NULL
lines	NULL
of	NULL
experiments	NULL
demonstrated	NULL
that	NULL
TPO	NULL
induces	NULL
activation	NULL
of	NULL
JAK2	NULL
,	NULL
STATS	NULL
,	NULL
mitogen-activated	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Morphological	NULL
|	NULL
characteristics	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
in	NULL
liquid	NULL
culture	NULL
.	NULL

Cytospin	NULL
smears	NULL
of	NULL
May-Giemsa-stained	NULL
(	NULL
A-C	NULL
;	NULL
original	NULL
magnification	NULL
,	NULL
x400	NULL
)	NULL
or	NULL
dianisidine-stained	NULL
(	NULL
D-F	NULL
;	NULL
original	NULL
magnification	NULL
,	NULL
x250	NULL
)	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

UT-7/GMT	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
(	NULL
1	NULL
ng/ml	NULL
;	NULL
A	NULL
and	NULL
D	NULL
)	NULL
,	NULL
EPO	NULL
(	NULL
1	NULL
unit/ml	NULL
;	NULL
8	NULL
and	NULL
E	NULL
)	NULL
,	NULL
or	NULL
TPO	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
C	NULL
and	NULL
F	NULL
)	NULL
.	NULL

One	NULL
week	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
preparation	NULL
of	NULL
cytospin	NULL
smears	NULL
.	NULL

IP	NULL
:	NULL
«	NULL
c-EPOR	NULL
Ld	NULL
ae	NULL
6°00	NULL
Q	NULL
$	NULL
&	NULL
=	NULL
|	NULL
Poe	NULL
|	NULL
Blot	NULL
:	NULL
«	NULL
-Ptyr	NULL
Blot	NULL
:	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

TPO	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
c-Mpl	NULL
but	NULL
not	NULL
EPOR	NULL
.	NULL

GM-CSF	NULL
was	NULL
removed	NULL
from	NULL
UT-7/GMT	NULL
cells	NULL
overnight	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
EPO	NULL
(	NULL
10	NULL
units/m	NULL
!	NULL
)	NULL

,	NULL
or	NULL
TPO	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
7	NULL
min	NULL
before	NULL
solubilization	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
protein	NULL
G-conjugated	NULL
anti-EPOR	NULL
(	NULL
eff	NULL
)	NULL
or	NULL
anti-c-Mpl	NULL
!	NULL

(	NULL
right	NULL
)	NULL
serum	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
eluted	NULL
with	NULL
buffer	NULL
containing	NULL
SDS	NULL
and	NULL
resolved	NULL
by	NULL
7.5	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
onto	NULL
a	NULL
PVDF	NULL
membrane	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-P-Tyr	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
a	NULL
representative	NULL
is	NULL
shown	NULL
.	NULL

protein	NULL
kinase	NULL
,	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
a	NULL
human	NULL
TPO-de-pendent	NULL
cell	NULL
line	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
TPO	NULL
activates	NULL
these	NULL
pathways	NULL
in	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

TPO	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
,	NULL
as	NULL
did	NULL
EPO	NULL
and	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

STATS	NULL
was	NULL
tyrosine	NULL
%	NULL
I	NULL
o	NULL
~	NULL
®	NULL
2	NULL
3	NULL
J|	NULL
5	NULL
5004	NULL
A	NULL
®	NULL
A	NULL
O	NULL
®	NULL
CC	NULL
[	NULL
o	NULL
a	NULL
4	NULL
L	NULL
0	NULL
{	NULL
0	NULL
1	NULL
10	NULL
100	NULL
TPO	NULL
(	NULL
ng/mL	NULL
)	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Competition	NULL
assay	NULL
between	NULL
TPO	NULL
and	NULL
EPO	NULL
for	NULL
binding	NULL
to	NULL
EPOR	NULL
.	NULL

The	NULL
specific	NULL
binding	NULL
assay	NULL
of	NULL
b-EPO	NULL
to	NULL
EPORs	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
unlabeled	NULL
TPO	NULL
(	NULL
up	NULL
to	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Columns	NULL
,	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
bars	NULL
,	NULL
SD	NULL
.	NULL

phosphorylated	NULL
by	NULL
GM-CSF	NULL
and	NULL
EPO	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
de-gree	NULL
,	NULL
by	NULL
TPO	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
TPO	NULL
were	NULL
similar	NULL
to	NULL
EPO	NULL
;	NULL
phosphorylation	NULL
increased	NULL
5	NULL
min	NULL
after	NULL
stimulation	NULL
,	NULL
reached	NULL
a	NULL
maximum	NULL
489	NULL
490	NULL
-	NULL
Thrombopoietin	NULL
and	NULL
Erythropoiesis	NULL
IP	NULL
:	NULL
o-JAK2	NULL
«	NULL
°\	NULL
04	NULL
‘	NULL
é	NULL
&	NULL
«	NULL
&	NULL
``	NULL
,	NULL
.0	NULL
0°	NULL
8	NULL
0	NULL
&	NULL
@	NULL
I	NULL
‘	NULL
M-	NULL
Mﬂnlf	NULL
’	NULL
IP	NULL
:	NULL
o-Stat5	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Activation	NULL
of	NULL
JAK2-STATS5	NULL
pathway	NULL
by	NULL
TPO	NULL
.	NULL

GM-CSF	NULL
was	NULL
re-0	NULL
moved	NULL
from	NULL
UT-7/GMT	NULL
cells	NULL
overnight	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
&	NULL
06	NULL
é	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/	NULL
mi	NULL
)	NULL
,	NULL
EPO	NULL
(	NULL
10	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
TPO	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
10	NULL
min	NULL
before	NULL
solubilization	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunopre-4—	NULL
cipitated	NULL
with	NULL
protein	NULL
G-conjugated	NULL
anti-JAK2	NULL
(	NULL
left	NULL
)	NULL
or	NULL
anti-STATS	NULL
(	NULL
right	NULL
)	NULL
polyclonal	NULL
antibody	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
eluted	NULL
with	NULL
buffer	NULL
con	NULL
Blot	NULL
:	NULL
«	NULL
c-Ptyr	NULL
Blot	NULL
:	NULL
«	NULL
c-Ptyr	NULL
taining	NULL
SDS	NULL
and	NULL
resolved	NULL
by	NULL
7.5	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
onto	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
the	NULL
membranes	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-P-Tyr	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
polyclonal	NULL
Cap	NULL
amer	NULL
wwe	NULL
Gin	NULL
|	NULL
Blot	NULL
:	NULL
o-JAK2	NULL
level	NULL
at	NULL
15-30	NULL
min	NULL
,	NULL
and	NULL
declined	NULL
at	NULL
60	NULL
min	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
with	NULL
GM-CSF	NULL
treatment	NULL
,	NULL
the	NULL
phosphorylation	NULL
increased	NULL
at	NULL
5	NULL
min	NULL
,	NULL
reached	NULL
a	NULL
maximum	NULL
level	NULL
at	NULL
15	NULL
min	NULL
,	NULL
and	NULL
was	NULL
sustained	NULL
over	NULL
60	NULL
min	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
activity	NULL
was	NULL
significantly	NULL
and	NULL
equally	NULL
elevated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
GM-CSF	NULL
,	NULL
EPO	NULL
,	NULL
or	NULL
TPO	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mitogen-activated	NULL
protein	NULL
kinase	NULL
was	NULL
activated	NULL
at	NULL
10	NULL
min	NULL
with	NULL
each	NULL
cytokine	NULL
.	NULL

This	NULL
activity	NULL
was	NULL
relatively	NULL
retained	NULL
with	NULL
GM-CSF	NULL
treatment	NULL
,	NULL
but	NULL
it	NULL
declined	NULL
after	NULL
EPO	NULL
or	NULL
TPO	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TPO	NULL
Induces	NULL
Expression	NULL
of	NULL
Erythroid-specific	NULL
Genes	NULL
and	NULL
Transcription	NULL
Factors	NULL
.	NULL

To	NULL
further	NULL
elucidate	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
TPO	NULL
induces	NULL
hemoglobinization	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
genes	NULL
associated	NULL
with	NULL
erythroid	NULL
differentiation	NULL
.	NULL

There	NULL
was	NULL
two	NULL
peaks	NULL
of	NULL
GATA-1	NULL
expression	NULL
after	NULL
EPO	NULL
stimulation	NULL
:	NULL
one	NULL
early	NULL
(	NULL
6	NULL
h	NULL
)	NULL
and	NULL
a	NULL
second	NULL
later	NULL
peak	NULL
(	NULL
day	NULL
5	NULL
)	NULL
,	NULL
whereas	NULL
GATA-1	NULL
remained	NULL
significantly	NULL
unchanged	NULL
after	NULL
exposure	NULL
to	NULL
TPO	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

With	NULL
EPO	NULL
treatment	NULL
,	NULL
the	NULL
level	NULL
of	NULL
GATA-2	NULL
was	NULL
basically	NULL
correlated	NULL
with	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
GATA-2	NULL
mRNA	NULL
level	NULL
after	NULL
TPO	NULL
treatment	NULL
was	NULL
almost	NULL
the	NULL
same	NULL
as	NULL
those	NULL
after	NULL
EPO	NULL
treatment	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
ALAS-E	NULL
mRNA	NULL
was	NULL
observed	NULL
after	NULL
6	NULL
and	NULL
12	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
TPO	NULL
or	NULL
EPO	NULL
,	NULL
and	NULL
it	NULL
reached	NULL
maximum	NULL
levels	NULL
24	NULL
and	NULL
72	NULL
h	NULL
after	NULL
TPO	NULL
and	NULL
EPO	NULL
treatment	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
peak	NULL
was	NULL
sustained	NULL
until	NULL
day	NULL
7	NULL
with	NULL
both	NULL
cytokines	NULL
.	NULL

With	NULL
TPO	NULL
treatment	NULL
,	NULL
expression	NULL
of	NULL
NF-E2	NULL
mRNA	NULL
increased	NULL
after	NULL
3	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
reached	NULL
a	NULL
peak	NULL
at	NULL
6	NULL
h	NULL
,	NULL
and	NULL
was	NULL
sustained	NULL
thereafter	NULL
.	NULL

With	NULL
EPO	NULL
treatment	NULL
,	NULL
expression	NULL
of	NULL
NF-E2	NULL
gradually	NULL
elevated	NULL
,	NULL
reached	NULL
a	NULL
maximum	NULL
at	NULL
day	NULL
3	NULL
,	NULL
and	NULL
thereafter	NULL
was	NULL
sustained	NULL
.	NULL

The	NULL
peaks	NULL
of	NULL
y-globin	NULL
and	NULL
ALAS-E	NULL
mRNA	NULL
induced	NULL
by	NULL
TPO	NULL
appeared	NULL
earlier	NULL
than	NULL
those	NULL
induced	NULL
by	NULL
EPO	NULL
at	NULL
24	NULL
h	NULL
and	NULL
were	NULL
also	NULL
sustained	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
expression	NULL
of	NULL
GPllb	NULL
and	NULL
c-mp/	NULL
mRNAs	NULL
were	NULL
similar	NULL
with	NULL
both	NULL
cytokines	NULL
.	NULL

PF4	NULL
mRNA	NULL
was	NULL
detected	NULL
at	NULL
a	NULL
low	NULL
level	NULL
by	NULL
RT-PCR	NULL
in	NULL
pretreated	NULL
UT-7/GMT	NULL
antibodies	NULL
against	NULL
JAK2	NULL
or	NULL
STATS	NULL
to	NULL
confirm	NULL
equal	NULL
loading	NULL
of	NULL
samples	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

Blot	NULL
:	NULL
«	NULL
-Stat5	NULL
cells	NULL
.	NULL

After	NULL
3-5	NULL
days	NULL
of	NULL
exposure	NULL
to	NULL
TPO	NULL
,	NULL
PF4	NULL
mRNA	NULL
became	NULL
undetectable	NULL
and	NULL
then	NULL
reappeared	NULL
after	NULL
7	NULL
days	NULL
of	NULL
exposure	NULL
to	NULL
TPO	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
dianisidine-positive	NULL
cells	NULL
disappeared	NULL
after	NULL
2	NULL
weeks	NULL
of	NULL
exposure	NULL
to	NULL
TPO	NULL
without	NULL
decreased	NULL
cell	NULL
viability	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

EPO	NULL
did	NULL
not	NULL
induce	NULL
PF4	NULL
mRNA	NULL
during	NULL
the	NULL
observation	NULL
periods	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

TPO	NULL
Predominantly	NULL
Induces	NULL
Fetal	NULL
and	NULL
Adult	NULL
Hb	NULL
.	NULL

To	NULL
elucidate	NULL
whether	NULL
the	NULL
pattern	NULL
of	NULL
Hb	NULL
induced	NULL
by	NULL
each	NULL
cyto-kine	NULL
was	NULL
different	NULL
,	NULL
we	NULL
examined	NULL
IEF	NULL
of	NULL
UT-7/GMT	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
of	NULL
growth	NULL
factors	NULL
and	NULL
incubated	NULL
with	NULL
fresh	NULL
medium	NULL
containing	NULL
the	NULL
indicated	NULL
cytokines	NULL
.	NULL

After	NULL
5	NULL
days	NULL
of	NULL
treatment	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
applied	NULL
to	NULL
IEF	NULL
analysis	NULL
.	NULL

Slight	NULL
amounts	NULL
of	NULL
HbF	NULL
(	NULL
a2y2	NULL
)	NULL
,	NULL
HbA	NULL
(	NULL
«	NULL
28B2	NULL
)	NULL
,	NULL
HbX	NULL
(	NULL
e2y2	NULL
)	NULL
,	NULL
HbBart	NULL
's	NULL
(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
HbPortland	NULL
(	NULL
{	NULL
2y2	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
UT-7/	NULL
GMT	NULL
cells	NULL
maintained	NULL
with	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

With	NULL
EPO	NULL
treatment	NULL
,	NULL
HbF	NULL
(	NULL
«	NULL
2y2	NULL
)	NULL
was	NULL
induced	NULL
~2-fold	NULL
,	NULL
HbA	NULL
(	NULL
«	NULL
2B2	NULL
)	NULL
was	NULL
induced	NULL
3-fold	NULL
,	NULL
and	NULL
HbX	NULL
(	NULL
e27y2	NULL
)	NULL
,	NULL
HbBart	NULL
's	NULL
(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
HbPortland	NULL
(	NULL
£272	NULL
)	NULL
were	NULL
all	NULL
induced	NULL
5-fold	NULL
,	NULL
compared	NULL
with	NULL
GM-CSF	NULL
treatment	NULL
.	NULL

With	NULL
TPO	NULL
treatment	NULL
,	NULL
HbF	NULL
(	NULL
a272	NULL
)	NULL
and	NULL
HbA	NULL
(	NULL
«	NULL
2B2	NULL
)	NULL
were	NULL
induced	NULL
>	NULL
4-fold	NULL
compared	NULL
with	NULL
GM-CSF	NULL
,	NULL
but	NULL
HbX	NULL
(	NULL
e2y2	NULL
)	NULL
,	NULL
HbBart	NULL
's	NULL
(	NULL
y4	NULL
)	NULL
,	NULL
and	NULL
HbPortland	NULL
{	NULL
(	NULL
{	NULL
2y2	NULL
)	NULL
were	NULL
decreased	NULL
compared	NULL
with	NULL
GM-CSF	NULL
.	NULL

Thus	NULL
,	NULL
whereas	NULL
EPO	NULL
induced	NULL
embryonic	NULL
,	NULL
fetal	NULL
,	NULL
and	NULL
adult	NULL
Hb	NULL
synthesis	NULL
,	NULL
TPO	NULL
induced	NULL
only	NULL
fetal	NULL
and	NULL
adult	NULL
Hb	NULL
synthesis	NULL
.	NULL

To	NULL
detect	NULL
the	NULL
Hb	NULL
pattern	NULL
of	NULL
UT-7/	NULL
GMT	NULL
under	NULL
maintenance	NULL
conditions	NULL
,	NULL
the	NULL
protein	NULL
volume	NULL
loaded	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
Lane	NULL
5	NULL
,	NULL
was	NULL
double	NULL
that	NULL
loaded	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
Lane	NULL
3	NULL
or	NULL
4	NULL
,	NULL
because	NULL
the	NULL
Hb	NULL
content	NULL
of	NULL
untreated	NULL
UT-7/GMT	NULL
was	NULL
too	NULL
low	NULL
to	NULL
detect	NULL
.	NULL

Relationship	NULL
between	NULL
TPO-induced	NULL
Hemoglobinization	NULL
and	NULL
Cell	NULL
Cycle	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
TPO	NULL
induced	NULL
G	NULL
,	NULL
prolongation	NULL
in	NULL
UT-7/GMT	NULL
cells	NULL
because	NULL
G	NULL
,	NULL
prolongation	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
a	NULL
trigger	NULL
of	NULL
erythroid	NULL
differentiation	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
G/G	NULL
,	NULL
phase	NULL
was	NULL
unchanged	NULL
24	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
10	NULL
ng/ml	NULL
TPO	NULL
(	NULL
Fig	NULL
.	NULL

10A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
even	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
-	NULL
491	NULL
A	NULL
GATA	NULL
|	NULL
-	NULL
»	NULL
a	NULL
#	NULL
ag	NULL
to	NULL
me	NULL
uo	NULL
P	NULL
ts	NULL
GATA-2	NULL
f	NULL
12	NULL
T	NULL
awed	NULL
E	NULL
pae	NULL
NF-E2	NULL
—	NULL
”	NULL
-	NULL
.	NULL

!	NULL

gii§	NULL
EPOR	NULL
e	NULL
``	NULL
-O-	NULL
ALAS-E	NULL
ALAS-E	NULL
P*	NULL
-	NULL
.	NULL

u	NULL
-x-	NULL
y-globin	NULL
yglobin	NULL
|	NULL
--	NULL
»	NULL
--	NULL
CB	NULL
aB	NULL
an	NULL
GPllb	NULL
women	NULL
|	NULL
Cpe	NULL
Seach	NULL
5	NULL
|	NULL
-2a-GPlib	NULL
c-Mpl	NULL
2	NULL
3	NULL
,	NULL
b	NULL
A	NULL
ooc	NULL
.	NULL

CWM	NULL
-	NULL
Wims	NULL
atis	NULL
-z-c-Mpl	NULL
3	NULL
185	NULL
(	NULL
Reis	NULL
a	NULL
:	NULL
'	NULL
6	NULL
%	NULL
st	NULL
#	NULL
i	NULL
``	NULL
3	NULL
1	NULL
EPO	NULL
:	NULL
0	NULL
1h	NULL
3h	NULL
6h	NULL
12h	NULL
24h	NULL
D3	NULL
D5	NULL
D7	NULL
0	NULL
ih	NULL
3h	NULL
Sh	NULL
12h	NULL
24h	NULL
D3	NULL
D5	NULL
D7	NULL
B	NULL
4	NULL
-O-	NULL
GATA-1	NULL
GATA	NULL
!	NULL

|t	NULL
#	NULL
t-	NULL
#	NULL
``	NULL
tot	NULL
tnd	NULL
toot	NULL
tas	NULL
tnd	NULL
ont	NULL
bons	NULL
!	NULL

-+-	NULL
GATA-2	NULL
3	NULL
|	NULL
--	NULL
NF-E2	NULL
cata2|	NULL
tu	NULL
@	NULL
&	NULL
°	NULL
IC	NULL
*	NULL
\	NULL
€	NULL
-	NULL
+-	NULL
EPOR	NULL
2—	NULL
NF-E2	NULL
|	NULL
_-	NULL
»	NULL
am	NULL
»	NULL
Stud	NULL
CaP	NULL
tat	NULL
P	NULL
OP	NULL
tap	NULL
owt	NULL
1-1	NULL
EPOR	NULL
4	NULL
T	NULL
T	NULL
t	NULL
T	NULL
T	NULL
I	NULL
T	NULL
U	NULL
T	NULL
ALAS-E	NULL
vo	NULL
wet	NULL
tat	NULL
<	NULL
>	NULL
uud	NULL
|	NULL
.	NULL
)	NULL

-o	NULL
--	NULL
x-	NULL
y-globin	NULL
y-globin	NULL
~	NULL
--	NULL
tut	NULL
#	NULL
--	NULL
-	NULL
&	NULL
aP	NULL
OD	NULL
»	NULL
ae	NULL
2-1-	NULL
L	NULL
it	NULL
.	NULL

-	NULL
—	NULL
~	NULL
5	NULL
ms	NULL
U	NULL
T	NULL
I	NULL
I	NULL
T	NULL
U	NULL
I	NULL
c-Mpi	NULL
o	NULL
|	NULL
th	NULL
.	NULL

With	NULL
a+	NULL
g	NULL
|	NULL
--	NULL
c-Mp	NULL
!	NULL

TPO	NULL
:	NULL
0	NULL
ih	NULL
3h	NULL
6h	NULL
12h	NULL
24h	NULL
D3	NULL
D5	NULL
D7	NULL
0	NULL
th	NULL
3h	NULL
6h	NULL
12h	NULL
24h	NULL
D3	NULL
D5	NULL
D7	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
mRNA	NULL
expression	NULL
of	NULL
megakaryocyte	NULL
and	NULL
erythroid	NULL
lineage-associated	NULL
genes	NULL
induced	NULL
by	NULL
EPO	NULL
or	NULL
TPO	NULL
.	NULL

UT-7/GMT	NULL
cells	NULL
were	NULL
perfectly	NULL
washed	NULL
out	NULL
GM-CSF	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
tissue	NULL
culture	NULL
flasks	NULL
with	NULL
EPO	NULL
(	NULL
A	NULL
;	NULL
1	NULL
unit/m	NULL
!	NULL
)	NULL

or	NULL
TPO	NULL
(	NULL
B	NULL
;	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
prepared	NULL
for	NULL
isolation	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
.	NULL

The	NULL
expressions	NULL
of	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
NF-E2	NULL
,	NULL
EPOR	NULL
,	NULL
ALAS-E	NULL
,	NULL
y-globin	NULL
,	NULL
GPlib	NULL
,	NULL
and	NULL
c-mp	NULL
!	NULL

mRNAs	NULL
were	NULL
examined	NULL
by	NULL
Northern	NULL
blotting	NULL
(	NULL
eft	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
the	NULL
mRNAs	NULL
were	NULL
quantitated	NULL
and	NULL
normalized	NULL
to	NULL
18S	NULL
rRNA	NULL
levels	NULL
(	NULL
right	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
a	NULL
representative	NULL
is	NULL
shown	NULL
.	NULL

492	NULL
-	NULL
Thrombopoietin	NULL
and	NULL
Erythropoiesis	NULL
co	NULL
\D	NULL
4	NULL
a	NULL
2	NULL
A	NULL
&	NULL
&	NULL
7	NULL
A	NULL
mp	NULL
!	NULL

I	NULL
£	NULL
J	NULL
*t	NULL
J	NULL
V	NULL
u	NULL
1353-1078	NULL
872-1	NULL
603-	NULL
310-7	NULL
281-271+	NULL
234-DO	NULL
D5	NULL
D7	NULL
D14	NULL
D5	NULL
D7	NULL
D14	NULL
DDW	NULL
Po	NULL
EPO	NULL
¢X174-Haeill	NULL
PF4	NULL
cDNA	NULL
B	NULL
..	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
(	NULL
bp	NULL
)	NULL
1353	NULL
1078	NULL
872-1	NULL
603-	NULL
po	NULL
Ds	NULL
_D7	NULL
Di4	NULL
D5	NULL
D7	NULL
D14	NULL
EPO	NULL
$	NULL
X174-Haelll	NULL
'	NULL
O	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

PF4	NULL
mRNA	NULL
was	NULL
detectable	NULL
after	NULL
a	NULL
7-day	NULL
treatment	NULL
with	NULL
TPO	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
treated	NULL
with	NULL
TPO	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
EPO	NULL
{	NULL
1	NULL
unit/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
Lanes	NULL
1-7	NULL
)	NULL
.	NULL

A	NULL
,	NULL
expression	NULL
of	NULL
PF4	NULL
mRNA	NULL
.	NULL

Ten	NULL
and	NULL
1	NULL
ng	NULL
of	NULL
PF4	NULL
cDNA	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
controls	NULL
(	NULL
Lanes	NULL
8	NULL
and	NULL
9	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Distilled	NULL
water	NULL
(	NULL
DDW	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
Lane	NULL
10	NULL
)	NULL
.	NULL

B	NULL
,	NULL
B-actin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
semiquantitative	NULL
control	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ng	NULL
TPO/mIl	NULL
,	NULL
GM-CSF	NULL
reduced	NULL
the	NULL
G/G	NULL
,	NULL
number	NULL
(	NULL
Fig	NULL
.	NULL

108	NULL
)	NULL
and	NULL
inhibited	NULL
TPO-induced	NULL
hemoglobinization	NULL
(	NULL
Fig	NULL
.	NULL

10C	NULL
)	NULL
.	NULL

The	NULL
minimum	NULL
G/G	NULL
,	NULL
phase	NULL
and	NULL
maximum	NULL
cell	NULL
growth	NULL
were	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ng/m	NULL
!	NULL

GM-CSF	NULL
,	NULL
at	NULL
which	NULL
concentration	NULL
none	NULL
of	NULL
the	NULL
cells	NULL
became	NULL
dianisidine	NULL
positive	NULL
(	NULL
Fig	NULL
.	NULL

10C	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
a	NULL
high	NULL
dose	NULL
of	NULL
GM-CSF	NULL
shortened	NULL
the	NULL
TPO-induced	NULL
G	NULL
,	NULL
prolongation	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
TPO-induced	NULL
erythroid	NULL
differentiation	NULL
,	NULL
as	NULL
was	NULL
the	NULL
case	NULL
for	NULL
EPO	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
isolated	NULL
a	NULL
novel	NULL
subline	NULL
,	NULL
UT-7/GMT	NULL
,	NULL
which	NULL
can	NULL
differentiate	NULL
into	NULL
cells	NULL
with	NULL
mature	NULL
erythroid	NULL
properties	NULL
following	NULL
treatment	NULL
with	NULL
TPO	NULL
.	NULL

Using	NULL
this	NULL
subline	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
TPO	NULL
induced	NULL
hemoglobinization	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
TPO	NULL
signals	NULL
were	NULL
transduced	NULL
into	NULL
the	NULL
nucleus	NULL
via	NULL
its	NULL
specific	NULL
receptor	NULL
c-Mpl	NULL
but	NULL
not	NULL
EPOR	NULL
and	NULL
that	NULL
G	NULL
,	NULL
prolongation	NULL
was	NULL
a	NULL
critical	NULL
event	NULL
for	NULL
TPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
as	NULL
is	NULL
the	NULL
case	NULL
for	NULL
EPO	NULL
.	NULL

Because	NULL
the	NULL
sensitivity	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
to	NULL
TPO	NULL
is	NULL
much	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
GM-CSF	NULL
by	NULL
MTT	NULL
assay	NULL
,	NULL
G	NULL
,	NULL
prolongation	NULL
or	NULL
G	NULL
,	NULL
arrest	NULL
may	NULL
have	NULL
transiently	NULL
occurred	NULL
by	NULL
replacement	NULL
of	NULL
GM-CSF	NULL
with	NULL
TPO	NULL
.	NULL

If	NULL
so	NULL
,	NULL
this	NULL
hypothesis	NULL
provides	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
observation	NULL
that	NULL
TPO	NULL
induced	NULL
hemoglobinization	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
because	NULL
G	NULL
,	NULL
prolongation	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
a	NULL
trigger	NULL
of	NULL
erythroid	NULL
differentiation	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
TPO	NULL
on	NULL
the	NULL
entry	NULL
into	NULL
&	NULL
$	NULL
£	NULL
&	NULL
to	NULL
&	NULL
C	NULL
S	NULL
2	NULL
A2	NULL
&	NULL
$	NULL
FZ	NULL
&	NULL
&	NULL
3	NULL
HbA2—b	NULL
HbF	NULL
-	NULL
»	NULL
pct	NULL
HbAu—r	NULL
’	NULL
..	NULL
t	NULL
HbXI	NULL
Hb	NULL
Barts'=	NULL
>	NULL
HbPortIandlt	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

-	NULL
Hb	NULL
synthesis	NULL
after	NULL
TPO	NULL
treatment	NULL
.	NULL

UT-7/GMT	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
TPO	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

;	NULL
Lane	NULL
3	NULL
)	NULL
,	NULL
EPO	NULL
(	NULL
1	NULL
unit/ml	NULL
;	NULL
Lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
GM-CSF	NULL
(	NULL
1	NULL
ng/ml	NULL
;	NULL
Lane	NULL
5	NULL
)	NULL
.	NULL

After	NULL
5	NULL
days	NULL
of	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
prepared	NULL
for	NULL
IEF	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Cord	NULL
blood	NULL
(	NULL
Lane	NULL
1	NULL
)	NULL
and	NULL
adult	NULL
peripheral	NULL
blood	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
were	NULL
applied	NULL
for	NULL
controls	NULL
of	NULL
HbF	NULL
and	NULL
HbA	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
sample	NULL
extracted	NULL
from	NULL
GM-CSF-treated	NULL
UT-7/GMT	NULL
cells	NULL
was	NULL
applied	NULL
in	NULL
2-fold	NULL
excess	NULL
to	NULL
show	NULL
the	NULL
Hb	NULL
pattern	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

the	NULL
cell	NULL
cycle	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
TPO	NULL
to	NULL
growth	NULL
factor-deprived	NULL
UT-7/GMT	NULL
cells	NULL
caused	NULL
a	NULL
G	NULL
,	NULL
prolon-gation	NULL
.	NULL

However	NULL
,	NULL
1	NULL
ng/ml	NULL
GM-CSF	NULL
shortened	NULL
the	NULL
G	NULL
,	NULL
prolon-gation	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPO	NULL
,	NULL
presumably	NULL
mediated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
genes	NULL
leading	NULL
to	NULL
entry	NULL
into	NULL
cell	NULL
cycle	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
a	NULL
relatively	NULL
high	NULL
dose	NULL
of	NULL
GM-CSF	NULL
would	NULL
inhibit	NULL
TPO-induced	NULL
hemoglobinization	NULL
and	NULL
promote	NULL
cell	NULL
proliferation	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
close	NULL
relationship	NULL
between	NULL
cell	NULL
cycle	NULL
and	NULL
TPO-induced	NULL
hemoglobinization	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
hypothesis	NULL
proposed	NULL
by	NULL
Carroll	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
12	NULL
)	NULL
that	NULL
induction	NULL
of	NULL
erythroid	NULL
differentiation	NULL
requires	NULL
G	NULL
,	NULL
prolongation	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
also	NULL
may	NULL
be	NULL
true	NULL
for	NULL
TPO	NULL
(	NULL
13	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
notion	NULL
can	NULL
not	NULL
completely	NULL
explain	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
TPO	NULL
induced	NULL
hemoglobinization	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
because	NULL
there	NULL
is	NULL
a	NULL
significant	NULL
difference	NULL
in	NULL
Hb	NULL
patterns	NULL
between	NULL
EPO	NULL
and	NULL
TPO	NULL
.	NULL

Although	NULL
this	NULL
concept	NULL
is	NULL
speculative	NULL
at	NULL
present	NULL
,	NULL
an	NULL
additional	NULL
mechanism	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
TPO-induced	NULL
erythroid	NULL
differentiation	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
TPO	NULL
induced	NULL
fetal	NULL
and	NULL
adult	NULL
Hb	NULL
synthesis	NULL
and	NULL
suppressed	NULL
embryonic	NULL
Hb	NULL
synthesis	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
results	NULL
,	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
erythroid	NULL
cells	NULL
differentiated	NULL
from	NULL
the	NULL
murine	NULL
yolk	NULL
sac	NULL
by	NULL
stimulation	NULL
with	NULL
TPO	NULL
were	NULL
definitive	NULL
erythrocytes	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
different	NULL
patterns	NULL
of	NULL
Hb	NULL
expression	NULL
induced	NULL
by	NULL
EPO	NULL
and	NULL
TPO	NULL
indicate	NULL
two	NULL
possibil-ities	NULL
.	NULL

One	NULL
is	NULL
that	NULL
TPO	NULL
acts	NULL
predominantly	NULL
on	NULL
the	NULL
precursor	NULL
,	NULL
which	NULL
will	NULL
differentiate	NULL
to	NULL
definitive	NULL
erythrocytes	NULL
,	NULL
but	NULL
not	NULL
on	NULL
those	NULL
which	NULL
will	NULL
differentiate	NULL
to	NULL
primitive	NULL
erythrocytes	NULL
.	NULL

It	NULL
was	NULL
recently	NULL
reported	NULL
that	NULL
primitive	NULL
and	NULL
definitive	NULL
erythrocytes	NULL
developed	NULL
from	NULL
different	NULL
precursors	NULL
(	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
because	NULL
UT-7/GMT	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
single	NULL
cell	NULL
,	NULL
this	NULL
notion	NULL
seems	NULL
less	NULL
likely	NULL
and	NULL
remains	NULL
a	NULL
current	NULL
controversy	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
second	NULL
possibility	NULL
is	NULL
that	NULL
TPO	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
Hb	NULL
switch-ing	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
Hb	NULL
switches	NULL
from	NULL
embryonic	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
50	NULL
50	NULL
A	NULL
B	NULL
C	NULL
&	NULL
€	NULL
€	NULL
r	NULL
2	NULL
a	NULL
E	NULL
E3	NULL
8	NULL
$	NULL
©	NULL
ao	NULL
©	NULL
40-	NULL
a	NULL
S*	NULL
S*	NULL
``	NULL
3	NULL
0	NULL
0	NULL
a	NULL
207	NULL
3	NULL
3	NULL
£	NULL
.o	NULL
0	NULL
M	NULL
C	NULL
f-	NULL
5	NULL
o	NULL
30	NULL
=	NULL
--	NULL
-	NULL
~-	NULL
+	NULL
6	NULL
12	NULL
24	NULL
36	NULL
48	NULL
30	NULL
0	NULL
12	NULL
24	NULL
36	NULL
48	NULL
*T	NULL
oh	NULL
a	NULL
hour	NULL
hour	NULL
GM-CSF	NULL
(	NULL
ng/ml	NULL
)	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

Hemoglobinization	NULL
and	NULL
cell	NULL
cycle	NULL
after	NULL
TPO	NULL
treatment	NULL
.	NULL

A	NULL
,	NULL
percentages	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
/G	NULL
,	NULL
phase	NULL
after	NULL
stimulation	NULL
with	NULL
cytokines	NULL
.	NULL

UT-7/GMT	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
deprived	NULL
of	NULL
growth	NULL
factor	NULL
for	NULL
28	NULL
h	NULL
,	NULL
and	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
(	NULL
1	NULL
ng/ml	NULL
;	NULL
®	NULL
)	NULL
,	NULL
EPO	NULL
(	NULL
10	NULL
units/ml	NULL
;	NULL
@	NULL
,	NULL
or	NULL
TPO	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
O	NULL
}	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
6	NULL
,	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
after	NULL
stimulation	NULL
for	NULL
cell	NULL
cycle	NULL
analysis	NULL
.	NULL

B	NULL
,	NULL
effect	NULL
of	NULL
increasing	NULL
concentration	NULL
of	NULL
GM-CSF	NULL
(	NULL
0	NULL
ng/m	NULL
!	NULL

,	NULL
0	NULL
;	NULL
0.01	NULL
ng/m	NULL
!	NULL

,	NULL
0	NULL
;	NULL
0.1	NULL
ng/ml	NULL
,	NULL
©	NULL
;	NULL
1	NULL
ng/ml	NULL
,	NULL
@	NULL
;	NULL
and	NULL
10	NULL
ng/m	NULL
!	NULL

,	NULL
V	NULL
)	NULL
on	NULL
the	NULL
cell	NULL
cycle	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
constant	NULL
concentration	NULL
of	NULL
TPO	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

C	NULL
,	NULL
suppression	NULL
by	NULL
GM-CSF	NULL
of	NULL
TPO-induced	NULL
hemoglobinization	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

UT-7/GMT	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
GM-CSF	NULL
(	NULL
0.01-10	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ng/ml	NULL
TPO	NULL
.	NULL

Five	NULL
days	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
stained	NULL
with	NULL
dianisidine	NULL
,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

to	NULL
fetal	NULL
globin	NULL
gene	NULL
is	NULL
suggested	NULL
to	NULL
be	NULL
autonomous	NULL
by	NULL
experiments	NULL
with	NULL
transgenic	NULL
mice	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
TPO	NULL
may	NULL
directly	NULL
or	NULL
indirectly	NULL
affect	NULL
the	NULL
transcriptional	NULL
silencer	NULL
or	NULL
negative	NULL
regulator	NULL
of	NULL
embryonic	NULL
globin	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
further	NULL
investigation	NULL
will	NULL
be	NULL
required	NULL
to	NULL
address	NULL
this	NULL
issue	NULL
.	NULL

TPO	NULL
also	NULL
induced	NULL
ALAS-E	NULL
mRNA	NULL
in	NULL
UT-7/GMT	NULL
cells	NULL
,	NULL
as	NULL
did	NULL
EPO	NULL
.	NULL

ALAS-E	NULL
is	NULL
an	NULL
erythroid-specific	NULL
isozyme	NULL
of	NULL
5-aminolevulinate	NULL
synthetase	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
heme	NULL
synthesis	NULL
.	NULL

Because	NULL
decreased	NULL
ALAS-E	NULL
activity	NULL
due	NULL
to	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
ALAS-E	NULL
gene	NULL
is	NULL
seen	NULL
in	NULL
patients	NULL
with	NULL
X-linked	NULL
sideroblastic	NULL
anemia	NULL
(	NULL
18	NULL
)	NULL
,	NULL
ALAS-E	NULL
must	NULL
be	NULL
critical	NULL
to	NULL
the	NULL
hemoglobinization	NULL
process	NULL
that	NULL
requires	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
heme	NULL
for	NULL
Hb	NULL
synthesis	NULL
.	NULL

Analysis	NULL
of	NULL
genomic	NULL
DNA	NULL
clones	NULL
encoding	NULL
human	NULL
ALAS-E	NULL
gene	NULL
revealed	NULL
that	NULL
a	NULL
cluster	NULL
of	NULL
cis-acting	NULL
elements	NULL
involved	NULL
in	NULL
determining	NULL
erythroid-specific	NULL
transcriptional	NULL
activation	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
GATA-1	NULL
,	NULL
activator	NULL
protein-1/NF-E2	NULL
,	NULL
CACCC	NULL
,	NULL
and	NULL
CCAAT	NULL
factor	NULL
binding	NULL
se-quences	NULL
,	NULL
were	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
ALAS-E	NULL
gene	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
dynamic	NULL
kinetics	NULL
of	NULL
y-globin	NULL
and	NULL
ALAS-E	NULL
mRNAs	NULL
paralleled	NULL
those	NULL
of	NULL
NF-E2	NULL
mRNA	NULL
in	NULL
TPO-	NULL
or	NULL
EPO-treated	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

Although	NULL
NF-E2	NULL
was	NULL
found	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
terminal	NULL
maturation	NULL
of	NULL
megakaryocytes	NULL
rather	NULL
than	NULL
for	NULL
erythroid	NULL
differentiation	NULL
(	NULL
20	NULL
)	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-E2	NULL
is	NULL
involved	NULL
in	NULL
a-	NULL
and	NULL
B-globin	NULL
gene	NULL
expression	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
NF-E2	NULL
plays	NULL
some	NULL
role	NULL
in	NULL
TPO-induced	NULL
hemoglobinization	NULL
in	NULL
this	NULL
system	NULL
.	NULL

When	NULL
TPO-treated	NULL
cells	NULL
were	NULL
again	NULL
exposed	NULL
to	NULL
a	NULL
maintenance	NULL
dose	NULL
of	NULL
GM-CSF	NULL
alone	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
cells	NULL
became	NULL
negative	NULL
for	NULL
dianisidine	NULL
staining	NULL
within	NULL
1	NULL
week	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
TPO-induced	NULL
hemoglobinization	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
is	NULL
reversible	NULL
.	NULL

Therefore	NULL
,	NULL
GM-CSF	NULL
may	NULL
influence	NULL
gene	NULL
expression	NULL
required	NULL
for	NULL
lineage	NULL
commitment	NULL
or	NULL
differentiation	NULL
.	NULL

This	NULL
hypothesis	NULL
has	NULL
previously	NULL
been	NULL
proposed	NULL
by	NULL
ourselves	NULL
and	NULL
other	NULL
laboratories	NULL
(	NULL
9	NULL
,	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
TPO	NULL
induced	NULL
erythropoiesis	NULL
through	NULL
binding	NULL
of	NULL
TPO	NULL
to	NULL
the	NULL
EPOR	NULL
.	NULL

First	NULL
,	NULL
TPO	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
c-Mpl	NULL
but	NULL
not	NULL
EPOR	NULL
,	NULL
suggesting	NULL
that	NULL
TPO	NULL
did	NULL
not	NULL
activate	NULL
EPOR	NULL
.	NULL

Second	NULL
,	NULL
TPO	NULL
did	NULL
not	NULL
compete	NULL
with	NULL
binding	NULL
of	NULL
EPO	NULL
to	NULL
EPOR	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
in	NULL
the	NULL
range	NULL
of	NULL
1-100	NULL
ng/m	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
other	NULL
groups	NULL
reported	NULL
that	NULL
anti-EPO	NULL
neutralizing	NULL
antibodies	NULL
did	NULL
not	NULL
block	NULL
TPO-induced	NULL
erythroid	NULL
maturation	NULL
(	NULL
24	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
strongly	NULL
suggest	NULL
that	NULL
TPO	NULL
has	NULL
a	NULL
direct	NULL
effect	NULL
on	NULL
erythroid	NULL
progenitors	NULL
through	NULL
TPO-c-Mpl	NULL
signaling	NULL
.	NULL

This	NULL
notion	NULL
was	NULL
also	NULL
supported	NULL
by	NULL
evidence	NULL
that	NULL
TPO	NULL
can	NULL
rescue	NULL
production	NULL
of	NULL
erythroid	NULL
cells	NULL
from	NULL
erythroid	NULL
progenitors	NULL
in	NULL
mice	NULL
lacking	NULL
EPOR	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
understand	NULL
that	NULL
it	NULL
is	NULL
important	NULL
to	NULL
examine	NULL
whether	NULL
or	NULL
not	NULL
anti-EPOR	NULL
blocking	NULL
antibodies	NULL
suppress	NULL
TPO-induced	NULL
hemoglobinization	NULL
,	NULL
these	NULL
antibodies	NULL
are	NULL
not	NULL
presently	NULL
available	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
y-globin	NULL
mRNA	NULL
was	NULL
transiently	NULL
up-regulated	NULL
and	NULL
PF4	NULL
mRNA	NULL
was	NULL
transiently	NULL
down-regulated	NULL
in	NULL
TPO-treated	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
indicates	NULL
that	NULL
TPO	NULL
induced	NULL
erythroid	NULL
differentiation	NULL
and	NULL
blocked	NULL
megakaryocytic	NULL
differentiation	NULL
when	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
TPO	NULL
for	NULL
<	NULL
7	NULL
days	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
report	NULL
that	NULL
erythroid-specific	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
globins	NULL
,	NULL
were	NULL
shut	NULL
down	NULL
during	NULL
megakaryocytic	NULL
differentiation	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
evidence	NULL
that	NULL
TPO	NULL
induced	NULL
induction	NULL
of	NULL
y-globin	NULL
mRNA	NULL
earlier	NULL
than	NULL
did	NULL
EPO	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
may	NULL
explain	NULL
the	NULL
following	NULL
observation	NULL
:	NULL
TPO	NULL
induced	NULL
Hb	NULL
synthesis	NULL
of	NULL
fetal	NULL
and	NULL
adult	NULL
types	NULL
but	NULL
not	NULL
embryonic	NULL
globin	NULL
,	NULL
whereas	NULL
EPO	NULL
induced	NULL
synthesis	NULL
of	NULL
embryonic	NULL
,	NULL
fetal	NULL
,	NULL
and	NULL
adult	NULL
types	NULL
.	NULL

When	NULL
UT-7/GMT	NULL
cells	NULL
were	NULL
continuously	NULL
exposed	NULL
to	NULL
TPO	NULL
for	NULL
2	NULL
weeks	NULL
,	NULL
Hb-positive	NULL
cells	NULL
disappeared	NULL
,	NULL
and	NULL
PF4	NULL
mRNA	NULL
became	NULL
clearly	NULL
detectable	NULL
in	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
TPO	NULL
transiently	NULL
supported	NULL
erythropoiesis	NULL
.	NULL

Because	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
decreased	NULL
cell	NULL
viability	NULL
in	NULL
TPO-treated	NULL
UT-7/	NULL
GMT	NULL
cells	NULL
,	NULL
Hb-positive	NULL
cells	NULL
induced	NULL
by	NULL
a	NULL
short	NULL
exposure	NULL
to	NULL
493	NULL
494	NULL
-	NULL
Thrombopoietin	NULL
and	NULL
Erythropoiesis	NULL
TPO	NULL
may	NULL
have	NULL
finally	NULL
differentiated	NULL
into	NULL
cells	NULL
having	NULL
mature	NULL
megakaryocytic	NULL
properties	NULL
because	NULL
of	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
TPO	NULL
.	NULL

Because	NULL
TPO-induced	NULL
hemoglobinization	NULL
is	NULL
a	NULL
reversible	NULL
change	NULL
as	NULL
described	NULL
above	NULL
,	NULL
it	NULL
is	NULL
not	NULL
so	NULL
surprising	NULL
that	NULL
Hb-positive	NULL
cells	NULL
became	NULL
megakaryocytic	NULL
cells	NULL
later	NULL
.	NULL

This	NULL
problem	NULL
is	NULL
intriguing	NULL
and	NULL
important	NULL
;	NULL
however	NULL
,	NULL
we	NULL
have	NULL
not	NULL
yet	NULL
isolated	NULL
Hb-positive	NULL
cells	NULL
exposed	NULL
for	NULL
several	NULL
days	NULL
to	NULL
answer	NULL
this	NULL
question	NULL
.	NULL

Yoshimura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
described	NULL
an	NULL
activation	NULL
of	NULL
STATS	NULL
that	NULL
is	NULL
closely	NULL
linked	NULL
to	NULL
erythroid	NULL
differentiation	NULL
in	NULL
a	NULL
murine	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Chretien	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
reported	NULL
that	NULL
activation	NULL
of	NULL
STATS	NULL
induced	NULL
cell	NULL
growth	NULL
and	NULL
inhibited	NULL
erythroid	NULL
differentiation	NULL
in	NULL
a	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

Thus	NULL
,	NULL
whether	NULL
STATS	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
remains	NULL
controversial	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
STATS	NULL
was	NULL
commonly	NULL
activated	NULL
by	NULL
EPO	NULL
,	NULL
TPO	NULL
,	NULL
or	NULL
GM-CSF	NULL
,	NULL
and	NULL
GM-CSF	NULL
simultaneously	NULL
inhibited	NULL
TPO-	NULL
or	NULL
EPO-induced	NULL
hemoglobinization	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
STATS	NULL
activation	NULL
may	NULL
be	NULL
required	NULL
but	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
TPO-	NULL
or	NULL
EPO-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
.	NULL

A	NULL
third	NULL
factor	NULL
may	NULL
be	NULL
required	NULL
for	NULL
commitment	NULL
to	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Alterna-tively	NULL
,	NULL
the	NULL
dynamic	NULL
kinetics	NULL
of	NULL
STATS	NULL
activation	NULL
may	NULL
be	NULL
important	NULL
for	NULL
cytokine-specific	NULL
actions	NULL
,	NULL
as	NULL
we	NULL
have	NULL
proposed	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
constitutive	NULL
activation	NULL
of	NULL
STATS	NULL
is	NULL
required	NULL
for	NULL
TPO-induced	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
a	NULL
human	NULL
megakaryoblastic	NULL
cell	NULL
line	NULL
CMK	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
TPO	NULL
induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
UT-7/GMT	NULL
cells	NULL
via	NULL
its	NULL
specific	NULL
receptor	NULL
,	NULL
c-Mpl	NULL
.	NULL

An	NULL
apparent	NULL
difference	NULL
in	NULL
patterns	NULL
of	NULL
Hb	NULL
expression	NULL
between	NULL
EPO	NULL
and	NULL
TPO	NULL
treatment	NULL
implies	NULL
that	NULL
TPO	NULL
has	NULL
a	NULL
distinct	NULL
effect	NULL
on	NULL
erythropoiesis	NULL
,	NULL
although	NULL
we	NULL
must	NULL
consider	NULL
that	NULL
the	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
a	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Hematopoietic	NULL
Growth	NULL
Factors	NULL
and	NULL
Reagents	NULL
.	NULL

Recombinant	NULL
human	NULL
TPO	NULL
and	NULL
anti-c-Mpli	NULL
polyclonal	NULL
antibody	NULL
were	NULL
provided	NULL
by	NULL
the	NULL
Kirin	NULL
Brewery	NULL
Co.	NULL
,	NULL
Ltd.	NULL
(	NULL
Gunma	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
EPO	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
the	NULL
Life	NULL
Science	NULL
Research	NULL
Institute	NULL
of	NULL
Snow	NULL
Brand	NULL
Milk	NULL
Company	NULL
(	NULL
Tochigi	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
GM-CSF	NULL
was	NULL
provided	NULL
by	NULL
Sumitomo	NULL
Pharmaceutical	NULL
Company	NULL
(	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Human	NULL
EPOR	NULL
cDNA	NULL
was	NULL
cloned	NULL
from	NULL
UT-7	NULL
.	NULL

Human	NULL
cDNA	NULL
of	NULL
c-mp/	NULL
P	NULL
ctone	NULL
and	NULL
GPllb	NULL
cDNAs	NULL
were	NULL
gifts	NULL
of	NULL
Drs	NULL
.	NULL

Okada	NULL
(	NULL
Eisai	NULL
,	NULL
Tsukuba	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
Sakata	NULL
(	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Tochigi	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Human	NULL
PF4	NULL
and	NULL
NF-E2	NULL
cDNAs	NULL
were	NULL
gifts	NULL
of	NULL
Drs	NULL
.	NULL

Ponez	NULL
(	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
)	NULL
and	NULL
Itoh	NULL
(	NULL
Hirosaki	NULL
University	NULL
,	NULL
Hirosaki	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Human	NULL
ALAS-E	NULL
,	NULL
GATA-1	NULL
,	NULL
and	NULL
GATA-2	NULL
cDNAs	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
Yamamoto	NULL
(	NULL
Tsukuba	NULL
University	NULL
,	NULL
Tsukuba	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Human	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
human	NULL
EPOR	NULL
were	NULL
gifts	NULL
from	NULL
Drs	NULL
.	NULL

Miura	NULL
(	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
Elliott	NULL
(	NULL
Amgen	NULL
Inc.	NULL
,	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
human	NULL
y-globin	NULL
cDNA	NULL
and	NULL
a	NULL
human	NULL
ribosomal	NULL
DNA	NULL
probe	NULL
were	NULL
provided	NULL
by	NULL
the	NULL
Japanese	NULL
Cancer	NULL
Research	NULL
Resources	NULL
Bank	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

A	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
against	NULL
phosphotyrosine	NULL
(	NULL
anti-P-Tyr	NULL
;	NULL
4G10	NULL
)	NULL
and	NULL
polyclonal	NULL
anti-Jak2	NULL
antibody	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Polyclonal	NULL
antibody	NULL
against	NULL
STATSB	NULL
(	NULL
C-17	NULL
)	NULL
,	NULL
which	NULL
reacts	NULL
with	NULL
both	NULL
STATSA	NULL
and	NULL
STAT5B	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Isolation	NULL
of	NULL
the	NULL
Subline	NULL
UT-7/GMT	NULL
.	NULL

The	NULL
UT-7	NULL
cell	NULL
tine	NULL
was	NULL
established	NULL
from	NULL
bone	NULL
marrow	NULL
cells	NULL
obtained	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
megakaryocytic	NULL
leukemia	NULL
(	NULL
30	NULL
)	NULL
.	NULL

UT-7/GM	NULL
,	NULL
a	NULL
novel	NULL
subline	NULL
of	NULL
UT-7	NULL
,	NULL
was	NULL
isolated	NULL
after	NULL
long-term	NULL
culture	NULL
of	NULL
UT-7	NULL
with	NULL
GM-CSF	NULL
and	NULL
maintained	NULL
in	NULL
liquid	NULL
culture	NULL
with	NULL
IMDM	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
Laboratories	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Hyclone	NULL
Laboratories	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
and	NULL
1	NULL
ng/ml	NULL
GM-CSF	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Colony	NULL
Assay	NULL
.	NULL

The	NULL
colony	NULL
assay	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Fauser	NULL
and	NULL
Messner	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
UT-7/GMT	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
medium	NULL
containing	NULL
0.9	NULL
%	NULL
methylcellulose	NULL
(	NULL
Dow	NULL
Chem-ical	NULL
,	NULL
Midland	NULL
,	NULL
M	NULL
!	NULL
)	NULL

,	NULL
30	NULL
%	NULL
FCS	NULL
,	NULL
1	NULL
%	NULL
BSA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
and	NULL
1	NULL
ng/ml	NULL
GM-CSF	NULL
.	NULL

Aliquots	NULL
of	NULL
culture	NULL
medium	NULL
(	NULL
1	NULL
m	NULL
!	NULL
)	NULL

containing	NULL
500	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
35-mm	NULL
non-tissue	NULL
culture	NULL
dishes	NULL
(	NULL
Falcon	NULL
,	NULL
Oxnard	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
humidified	NULL
atmosphere	NULL
for	NULL
10	NULL
days	NULL
,	NULL
and	NULL
then	NULL
a	NULL
single	NULL
colony	NULL
was	NULL
picked	NULL
up	NULL
under	NULL
an	NULL
inverted	NULL
microscope	NULL
and	NULL
transferred	NULL
to	NULL
the	NULL
liquid	NULL
culture	NULL
medium	NULL
.	NULL

Colorimetric	NULL
MTT	NULL
Assay	NULL
for	NULL
Cell	NULL
Proliferation	NULL
.	NULL

Cell	NULL
growth	NULL
was	NULL
examined	NULL
by	NULL
a	NULL
colorimetric	NULL
assay	NULL
according	NULL
to	NULL
Mosmann	NULL
(	NULL
32	NULL
)	NULL
,	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
x	NULL
10	NULL
%	NULL
/0.1	NULL
ml	NULL
in	NULL
96-well	NULL
plates	NULL
in	NULL
IMDM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
EPO	NULL
,	NULL
GM-CSF	NULL
,	NULL
or	NULL
TPO	NULL
.	NULL

After	NULL
72	NULL
h	NULL
of	NULL
culture	NULL
at	NULL
37°C	NULL
,	NULL
20	NULL
ul	NULL
of	NULL
sterilized	NULL
5	NULL
mg/ml	NULL
MTT	NULL
(	NULL
Sigma	NULL
)	NULL
were	NULL
added	NULL
to	NULL
each	NULL
well	NULL
.	NULL

Following	NULL
a	NULL
2-h	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
100	NULL
u	NULL
)	NULL
of	NULL
10	NULL
%	NULL
SDS	NULL
were	NULL
added	NULL
to	NULL
each	NULL
well	NULL
to	NULL
dissolve	NULL
the	NULL
dark-blue	NULL
crystal	NULL
product	NULL
.	NULL

The	NULL
absorbance	NULL
(	NULL
4	NULL
)	NULL
was	NULL
measured	NULL
at	NULL
a	NULL
wavelength	NULL
of	NULL
595	NULL
nm	NULL
using	NULL
a	NULL
microplate	NULL
reader	NULL
{	NULL
model	NULL
3550	NULL
;	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
}	NULL
.	NULL

Morphological	NULL
Study	NULL
.	NULL

A	NULL
light	NULL
microscopy	NULL
examination	NULL
was	NULL
performed	NULL
on	NULL
May-Giemsa-stained	NULL
cytospin	NULL
preparations	NULL
.	NULL

Dianisidine	NULL
Staining	NULL
.	NULL

Hb	NULL
concentrations	NULL
were	NULL
examined	NULL
by	NULL
incubating	NULL
cells	NULL
in	NULL
serum-free	NULL
IMDM	NULL
containing	NULL
0.2	NULL
%	NULL
3,3'-dimethoxybenzidine	NULL
,	NULL
fast	NULL
blue	NULL
B	NULL
(	NULL
dianisidine	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
0.3	NULL
%	NULL
acetic	NULL
acid	NULL
,	NULL
and	NULL
0.3	NULL
%	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
33	NULL
)	NULL
.	NULL

RNA	NULL
Extraction	NULL
and	NULL
Northern	NULL
Blotting	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Chomczynski	NULL
and	NULL
Sacchi	NULL
(	NULL
34	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
agarose	NULL
formaldehyde	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
(	NULL
Zeta-probe	NULL
;	NULL
Bio-Rad	NULL
)	NULL
in	NULL
10x	NULL
SSC	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
human	NULL
cDNA	NULL
fragments	NULL
for	NULL
EPOR	NULL
,	NULL
y-globin	NULL
,	NULL
PF4	NULL
,	NULL
or	NULL
GPilb	NULL
,	NULL
with	NULL
human	NULL
ribosomal	NULL
DNA	NULL
probe	NULL
as	NULL
a	NULL
standard	NULL
control	NULL
.	NULL

These	NULL
fragments	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-*°P	NULL
]	NULL
CTP	NULL
by	NULL
random	NULL
priming	NULL
.	NULL

After	NULL
an	NULL
overnight	NULL
incubation	NULL
at	NULL
43°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
blots	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
2x	NULL
SSC	NULL
,	NULL
0.5	NULL
%	NULL
SSC	NULL
,	NULL
0.1	NULL
SSC	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
each	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
autoradiographed	NULL
using	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
mRNA	NULL
content	NULL
obtained	NULL
by	NULL
RNA	NULL
blot	NULL
hybridization	NULL
was	NULL
quantitated	NULL
by	NULL
densitometry	NULL
(	NULL
model	NULL
CS-9000	NULL
;	NULL
Shi-madzu	NULL
,	NULL
Kyoto	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Cell	NULL
Lysates	NULL
,	NULL
Immunoprecipitation	NULL
,	NULL
and	NULL
Western	NULL
Blotting	NULL
.	NULL

UT-7/GMT	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
growth	NULL
factor	NULL
for	NULL
24	NULL
h.	NULL
After	NULL
stimulation	NULL
with	NULL
cytokines	NULL
at	NULL
37°C	NULL
for	NULL
indicated	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
suspended	NULL
in	NULL
lysis	NULL
buffer	NULL
composed	NULL
of	NULL
20	NULL
mm	NULL
Tris	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
137	NULL
mm	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mm	NULL
phenylmethyisulfonyl	NULL
fluo-ride	NULL
,	NULL
15	NULL
mg/ml	NULL
!	NULL

aprotinin	NULL
,	NULL
and	NULL
2	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

After	NULL
20	NULL
min	NULL
of	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
insoluble	NULL
materials	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-EPOR	NULL
,	NULL
c-Mpl	NULL
,	NULL
JAK2	NULL
,	NULL
STATS	NULL
,	NULL
and	NULL
phosphotyrosine	NULL
(	NULL
4G10	NULL
)	NULL
polyclonal	NULL
antibody	NULL
attached	NULL
to	NULL
protein	NULL
G-Sepharose	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
in	NULL
an	NULL
Eppendorf	NULL
shaker	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
collected	NULL
by	NULL
a	NULL
brief	NULL
centrifugation	NULL
and	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
.	NULL

The	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
in	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
.	NULL

After	NULL
a	NULL
brief	NULL
centrifugation	NULL
,	NULL
the	NULL
supematants	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
elec-troblotted	NULL
onto	NULL
a	NULL
PVDF	NULL
membrane	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
blocked	NULL
with	NULL
1	NULL
%	NULL
BSA	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
appropriate	NULL
concentration	NULL
of	NULL
primary	NULL
antibodies	NULL
,	NULL
including	NULL
anti-P-Tyr	NULL
monoclonal	NULL
antibody	NULL
4G10	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
PBS	NULL
containing	NULL
Tween	NULL
20	NULL
(	NULL
1	NULL
:	NULL
2,000	NULL
)	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
1:10,000	NULL
dilution	NULL
of	NULL
rabbit	NULL
antimouse	NULL
or	NULL
goat	NULL
antirabbit	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibodies	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
a	NULL
second	NULL
wash	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
substrate	NULL
(	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
England	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
Hyperfilim	NULL
ECL	NULL
to	NULL
visualize	NULL
immunoreactive	NULL
bands	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
with	NULL
62.5	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
100	NULL
mm	NULL
B-mercaptoethanol	NULL
at	NULL
50°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
,	NULL
blocked	NULL
,	NULL
and	NULL
reprobed	NULL
.	NULL

Characterization	NULL
of	NULL
Hb	NULL
.	NULL

Hb	NULL
fractions	NULL
were	NULL
analyzed	NULL
by	NULL
IEF	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
previously	NULL
(	NULL
35	NULL
)	NULL
.	NULL

After	NULL
5	NULL
days	NULL
of	NULL
treatment	NULL
with	NULL
10	NULL
ng/mi	NULL
TPO	NULL
or	NULL
1	NULL
unit/ml	NULL
EPO	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
lysed	NULL
by	NULL
freezing	NULL
and	NULL
thawing	NULL
in	NULL
1	NULL
mi	NULL
of	NULL
0.05	NULL
%	NULL
KCN	NULL
.	NULL

Insoluble	NULL
proteins	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
3000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
IEF	NULL
on	NULL
a	NULL
slab	NULL
of	NULL
acrylamide	NULL
gel	NULL
with	NULL
LKB	NULL
ampholines	NULL
from	NULL
pH	NULL
6	NULL
to	NULL
pH	NULL
9	NULL
as	NULL
a	NULL
gradient	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
benzidine	NULL
staining	NULL
was	NULL
performed	NULL
to	NULL
de	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
tect	NULL
the	NULL
peroxidase	NULL
activity	NULL
of	NULL
Hb	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
Hbs	NULL
,	NULL
adult	NULL
RBCs	NULL
(	NULL
HbA	NULL
)	NULL
and	NULL
cord	NULL
blood	NULL
cells	NULL
(	NULL
HbF	NULL
)	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Cell	NULL
Cycle	NULL
Analysis	NULL
.	NULL

Cell-cycle	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
staining	NULL
DNA	NULL
with	NULL
propidium	NULL
iodide	NULL
in	NULL
preparation	NULL
for	NULL
flow	NULL
cytometry	NULL
with	NULL
the	NULL
FACScan/CellFIT	NULL
system	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
}	NULL
.	NULL

RT-PCR	NULL
and	NULL
Souther	NULL
Blotting	NULL
Analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
methods	NULL
of	NULL
Chomezynski	NULL
and	NULL
Sacchi	NULL
(	NULL
34	NULL
)	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
using	NULL
oligonucleotide	NULL
primers	NULL
as	NULL
follows	NULL
.	NULL

PF4	NULL
forward	NULL
(	NULL
5'-GCTGAAGCTGAAGAAGATGGG-3	NULL
'	NULL
)	NULL
and	NULL
reverse	NULL
(	NULL
5'-TAGCAAATGCACACACGTAGG-3	NULL
'	NULL
)	NULL
primers	NULL
amplified	NULL
a	NULL
247-bp	NULL
fragment	NULL
of	NULL
the	NULL
PF4	NULL
cDNA	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
EPO	NULL
forward	NULL
(	NULL
5'-GTCGGGCAGCAGGCCGTA-GAAGTCTGGCAG-3	NULL
``	NULL
)	NULL
and	NULL
reverse	NULL
(	NULL
5'-AGATGTCATTGCTGGCACTG-GAGTGTCCAT-3	NULL
'	NULL
)	NULL
primers	NULL
amplified	NULL
a	NULL
485-bp	NULL
fragment	NULL
of	NULL
the	NULL
EPO	NULL
cDNA	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
B-actin	NULL
forward	NULL
(	NULL
5'-TACCACTGGCATCGTGATGGACT-3	NULL
'	NULL
)	NULL
and	NULL
reverse	NULL
(	NULL
5'-TCCTTCTGCATCCTGTCGGCAAT-3	NULL
'	NULL
)	NULL
amplified	NULL
a	NULL
506-bp	NULL
fragment	NULL
of	NULL
the	NULL
B-actin	NULL
cDNA	NULL
as	NULL
a	NULL
semiquantitative	NULL
control	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
synthesized	NULL
by	NULL
reverse	NULL
transcription	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Boeh-ringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
using	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
primers	NULL
followed	NULL
by	NULL
35	NULL
PCR	NULL
amplification	NULL
cycles	NULL
(	NULL
94°C	NULL
for	NULL
20	NULL
s	NULL
,	NULL
primer	NULL
annealing	NULL
at	NULL
56°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
40	NULL
s	NULL
)	NULL
in	NULL
a	NULL
Perkin-Elmer	NULL
Cetus	NULL
Thermal	NULL
Cycler	NULL
(	NULL
GeneAmp	NULL
PCR	NULL
System	NULL
9600	NULL
,	NULL
Takara	NULL
Biochemicals	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
and	NULL
a	NULL
final	NULL
incubation	NULL
at	NULL
60°C	NULL
for	NULL
7	NULL
min	NULL
.	NULL

Amplification	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
TAE	NULL
gels	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
and	NULL
photo-graphed	NULL
.	NULL

Quantitative	NULL
Flow	NULL
Cytometric	NULL
Assay	NULL
of	NULL
EPOR	NULL
.	NULL

Quantitative	NULL
flow	NULL
cytometric	NULL
assay	NULL
of	NULL
EPOR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
39	NULL
)	NULL
.	NULL

We	NULL
performed	NULL
a	NULL
flow	NULL
cytometric	NULL
assay	NULL
using	NULL
cells	NULL
stained	NULL
with	NULL
b-EPO	NULL
and	NULL
a	NULL
streptavidin-RED670	NULL
conjugate	NULL
.	NULL

For	NULL
quantification	NULL
,	NULL
we	NULL
applied	NULL
the	NULL
Kol-mogorov-Smirnov	NULL
test	NULL
and	NULL
calculated	NULL
D.	NULL
D	NULL
was	NULL
evaluated	NULL
from	NULL
the	NULL
degree	NULL
of	NULL
shift	NULL
in	NULL
two	NULL
fluorescence	NULL
profiles	NULL
according	NULL
to	NULL
the	NULL
increase	NULL
in	NULL
fluorescence	NULL
intensity	NULL
due	NULL
to	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
b-EPO	NULL
to	NULL
EPORs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
unlabeled	NULL
TPO	NULL
(	NULL
up	NULL
to	NULL
100	NULL
ng/ml	NULL
}	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
the	NULL
Kirin	NULL
Brewery	NULL
Co.	NULL
for	NULL
providing	NULL
recombinant	NULL
human	NULL
TPO	NULL
and	NULL
anti-c-Mp	NULL
!	NULL

polyclonal	NULL
antibody	NULL
and	NULL
the	NULL
Life	NULL
Science	NULL
Research	NULL
Institute	NULL
of	NULL
Snow	NULL
Brand	NULL
Milk	NULL
Company	NULL
for	NULL
providing	NULL
recombinant	NULL
human	NULL
EPO	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
Tomoko	NULL
Ando	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
Motoko	NULL
Yoshida	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
Masayuki	NULL
Yamamoto	NULL
of	NULL
Tsukuba	NULL
University	NULL
for	NULL
his	NULL
helpful	NULL
suggestions	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kaushansky	NULL
,	NULL
K.	NULL
Thrombopoietin	NULL
:	NULL
the	NULL
primary	NULL
regulator	NULL
of	NULL
platelet	NULL
pro-duction	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
:	NULL
419-431	NULL
,	NULL
1995	NULL
.	NULL

2.	NULL
de	NULL
Sauvage	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Hass	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Spencer	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Malloy	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Austin	NULL
,	NULL
L.	NULL
,	NULL
Gumey	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Spencer	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Darbonne	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Hezel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Wong	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Kuang	NULL
,	NULL
W-J	NULL
.	NULL

,	NULL
Oles	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Hultgren	NULL
,	NULL
B.	NULL
,	NULL
Solberg	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Eaton	NULL
,	NULL
D.	NULL
L.	NULL
Stimulation	NULL
of	NULL
megakaryocytopoiesis	NULL
and	NULL
thrombopoie-sis	NULL
by	NULL
the	NULL
c-Mpl	NULL
ligand	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
369	NULL
:	NULL
533-538	NULL
,	NULL
1994	NULL
.	NULL

3	NULL
.	NULL

Foster	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Sprecher	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Grant	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Kramer	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Kuijper	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Holly	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Whitemore	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Heipel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Bell	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Ching	NULL
,	NULL
A.	NULL
F.	NULL
T.	NULL
,	NULL
McGrane	NULL
,	NULL
V.	NULL
,	NULL
Hart	NULL
,	NULL
C.	NULL
,	NULL
O'Hara	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Lok	NULL
,	NULL
S.	NULL
Human	NULL
thrombopoietin	NULL
:	NULL
gene	NULL
structure	NULL
,	NULL
cDNA	NULL
sequence	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
chromosomal	NULL
localiza-tion	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
;	NULL
13023-13027	NULL
,	NULL
1994	NULL
.	NULL

4	NULL
.	NULL

Kobayashi	NULL
,	NULL
M.	NULL
,	NULL
Laver	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Kato	NULL
,	NULL
T.	NULL
,	NULL
Miyazaki	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Ogawa	NULL
,	NULL
M.	NULL
Recombinant	NULL
human	NULL
thrombopoietin	NULL
(	NULL
Mp	NULL
!	NULL

ligand	NULL
)	NULL
enhances	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
:	NULL
2494-2499	NULL
,	NULL
1995	NULL
.	NULL

5	NULL
.	NULL

Kaushansky	NULL
,	NULL
K.	NULL
,	NULL
Nancy	NULL
,	NULL
L.	NULL
,	NULL
Grossman	NULL
,	NULL
A.	NULL
,	NULL
Humes	NULL
.	NULL

J.	NULL
,	NULL
Sprugel	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
and	NULL
Broudy	NULL
,	NULL
V.	NULL
C.	NULL
Thrombopoietin	NULL
expands	NULL
erythroid	NULL
,	NULL
granulocyte-macrophage	NULL
,	NULL
and	NULL
megakaryocytic	NULL
progenitor	NULL
cells	NULL
in	NULL
normal	NULL
and	NULL
myelosuppressed	NULL
mice	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

,	NULL
24	NULL
:	NULL
265-269	NULL
,	NULL
1996	NULL
.	NULL

6	NULL
.	NULL

Fibbe	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Heemskerk	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Laterveer	NULL
,	NULL
L.	NULL
,	NULL
Pruijt	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Foster	NULL
,	NULL
D.	NULL
,	NULL
Kaushansky	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Willemze	NULL
,	NULL
R.	NULL
Accelerated	NULL
reconstitution	NULL
of	NULL
platelets	NULL
and	NULL
erythrocytes	NULL
after	NULL
syngeneic	NULL
transplantation	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
derived	NULL
from	NULL
thrombopoietin	NULL
pretreated	NULL
donor	NULL
mice	NULL
.	NULL

Blood	NULL
,	NULL
86	NULL
:	NULL
3308-3313	NULL
,	NULL
1995	NULL
.	NULL

7	NULL
.	NULL

Papayannopoutou	NULL
,	NULL
T.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Farrer	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kaushansky	NULL
,	NULL
K.	NULL
Insights	NULL
into	NULL
the	NULL
cellular	NULL
mechanisms	NULL
of	NULL
erythropoietin-thrombopoietin	NULL
syn-ergy	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

,	NULL
24	NULL
:	NULL
660-669	NULL
,	NULL
1996	NULL
.	NULL

8	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Perkins	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Orkins	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
Thrombopoietin	NULL
rescues	NULL
in	NULL
vitro	NULL
erythroid	NULL
colony	NULL
formation	NULL
from	NULL
mouse	NULL
embryos	NULL
lacking	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
93	NULL
:	NULL
9126-9131	NULL
,	NULL
1996	NULL
.	NULL

9	NULL
.	NULL

Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Kirito	NULL
,	NULL
K.	NULL
,	NULL
Shimizu	NULL
,	NULL
R.	NULL
,	NULL
Kunitama	NULL
,	NULL
M.	NULL
,	NULL
Yamada	NULL
,	NULL
M.	NULL
,	NULL
Uchida	NULL
,	NULL
M.	NULL
,	NULL
Takatoku	NULL
,	NULL
M.	NULL
,	NULL
Eguchi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y.	NULL
in	NULL
vitro	NULL
development	NULL
of	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
cells	NULL
from	NULL
a	NULL
UT-7	NULL
subline	NULL
,	NULL
UT-7/GM	NULL
.	NULL

Blood	NULL
,	NULL
89	NULL
:	NULL
4021-4033	NULL
,	NULL
1997	NULL
.	NULL

10	NULL
.	NULL

Yamada	NULL
,	NULL
M.	NULL
,	NULL
Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Okada	NULL
,	NULL
K.	NULL
,	NULL
Kato	NULL
,	NULL
T.	NULL
,	NULL
Miyazaki	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y.	NULL
Thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
in	NULL
a	NULL
human	NULL
thrombopoietin-depend-ent	NULL
cell	NULL
line	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
217	NULL
:	NULL
230-237	NULL
,	NULL
1995	NULL
.	NULL

11	NULL
.	NULL

Kunitama	NULL
,	NULL
M.	NULL
,	NULL
Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Shimizu	NULL
,	NULL
R.	NULL
,	NULL
Yamada	NULL
,	NULL
M.	NULL
,	NULL
Kato	NULL
,	NULL
T.	NULL
,	NULL
Miyazaki	NULL
,	NULL
H.	NULL
,	NULL
Okada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
and	NULL
c-myc	NULL
gene	NULL
activation	NULL
pathways	NULL
in	NULL
thrombopoietin	NULL
signal	NULL
transduction	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
237	NULL
:	NULL
290-294	NULL
,	NULL
1997	NULL
.	NULL

12	NULL
.	NULL

Carroll	NULL
,	NULL
M.	NULL
,	NULL
Zhu	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
D'Andrea	NULL
,	NULL
A.	NULL
D.	NULL
Erythropoietin-induced	NULL
cellular	NULL
differentiation	NULL
requires	NULL
prolongation	NULL
of	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycie	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
:	NULL
2869-2873	NULL
,	NULL
1995	NULL
.	NULL

13	NULL
.	NULL

Kros	NULL
!	NULL

,	NULL
J.	NULL
,	NULL
Damen	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Krystal	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Humphries	NULL
,	NULL
R.	NULL
K.	NULL
Erythropoietin	NULL
and	NULL
interleukin-3	NULL
induce	NULL
distinct	NULL
events	NULL
in	NULL
erythropoietin	NULL
receptor-expressing	NULL
BA/F3	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
85	NULL
:	NULL
50-56	NULL
,	NULL
1995	NULL
.	NULL

14	NULL
.	NULL

Era	NULL
,	NULL
T.	NULL
,	NULL
Takahashi	NULL
,	NULL
T.	NULL
,	NULL
Sakai	NULL
,	NULL
K.	NULL
,	NULL
Kawamura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nakano	NULL
,	NULL
T.	NULL
Thrombopoietin	NULL
enhances	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
murine	NULL
yolk	NULL
sac	NULL
erythroid	NULL
progenitor	NULL
.	NULL

Blood	NULL
,	NULL
89	NULL
:	NULL
1207-1213	NULL
,	NULL
1997	NULL
.	NULL

15	NULL
.	NULL

Nakano	NULL
,	NULL
T.	NULL
,	NULL
Kodama	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Honjo	NULL
,	NULL
T.	NULL
in	NULL
vitro	NULL
development	NULL
of	NULL
primitive	NULL
and	NULL
definitive	NULL
erythrocytes	NULL
from	NULL
different	NULL
precursors	NULL
.	NULL

Science	NULL
(	NULL
Wash-ington	NULL
DC	NULL
)	NULL
,	NULL
272	NULL
:	NULL
722-724	NULL
,	NULL
1996	NULL
.	NULL

16	NULL
.	NULL

Kennedy	NULL
,	NULL
M.	NULL
,	NULL
Firpo	NULL
,	NULL
M.	NULL
,	NULL
Choi	NULL
,	NULL
K.	NULL
,	NULL
Wall	NULL
,	NULL
C.	NULL
,	NULL
Robertson	NULL
,	NULL
S.	NULL
,	NULL
Kabrun	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Keller	NULL
,	NULL
G.	NULL
A	NULL
common	NULL
precursor	NULL
for	NULL
primitive	NULL
erythropoiesis	NULL
and	NULL
definitive	NULL
haematopoiesis	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
386	NULL
:	NULL
488-493	NULL
,	NULL
1997	NULL
.	NULL

17	NULL
.	NULL

Raich	NULL
,	NULL
N.	NULL
,	NULL
Enver	NULL
,	NULL
T.	NULL
,	NULL
Nakamoto	NULL
,	NULL
B.	NULL
,	NULL
Josephson	NULL
,	NULL
B.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Stamatoyannopoulos	NULL
.	NULL

Autonomous	NULL
developmental	NULL
control	NULL
of	NULL
human	NULL
embryonic	NULL
globin	NULL
gene	NULL
switching	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Blood	NULL
,	NULL
79	NULL
:	NULL
861-864	NULL
,	NULL
1992	NULL
.	NULL

18	NULL
.	NULL

Cotter	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Rucknagel	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Bishop	NULL
,	NULL
D.	NULL
F.	NULL
X-linked	NULL
sideroblastic	NULL
anemia	NULL
:	NULL
identification	NULL
of	NULL
the	NULL
mutation	NULL
in	NULL
the	NULL
erythroid-specific	NULL
delta-aminolevulinate	NULL
synthetase	NULL
gene	NULL
(	NULL
ALAS2	NULL
)	NULL
in	NULL
the	NULL
original	NULL
family	NULL
described	NULL
by	NULL
Cooley	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
:	NULL
3915-3924	NULL
,	NULL
1994	NULL
.	NULL

19	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
Erythropoiesis	NULL
and	NULL
globin	NULL
gene	NULL
expression	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NF-E2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
:	NULL
8690-8694	NULL
,	NULL
1995	NULL
.	NULL

20	NULL
.	NULL

Conboy	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Cox	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Bottomley	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Bawden	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
May	NULL
,	NULL
B.	NULL
K.	NULL
Human	NULL
erythroid	NULL
5-aminolevulinate	NULL
synthetase	NULL
.	NULL

Gene	NULL
structure	NULL
and	NULL
species-specific	NULL
differences	NULL
in	NULL
alternative	NULL
RNA	NULL
splicing	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
267	NULL
:	NULL
18753-18758	NULL
,	NULL
1992	NULL
.	NULL

21	NULL
.	NULL

Lu	NULL
,	NULL
S-J	NULL
.	NULL

,	NULL
Rowan	NULL
,	NULL
S.	NULL
,	NULL
Bani	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Ben-David	NULL
,	NULL
Y.	NULL
Retroviral	NULL
integration	NULL
within	NULL
the	NULL
Fli-2	NULL
locus	NULL
results	NULL
in	NULL
inactivation	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
NF-E2	NULL
in	NULL
Friend	NULL
erythroleukemias	NULL
:	NULL
evidence	NULL
that	NULL
NF-E2	NULL
is	NULL
essential	NULL
for	NULL
globin	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
:	NULL
8398-8402	NULL
,	NULL
1994	NULL
.	NULL

22	NULL
.	NULL

Hermine	NULL
,	NULL
O.	NULL
,	NULL
Mayeux	NULL
,	NULL
P.	NULL
,	NULL
Titeux	NULL
,	NULL
M.	NULL
,	NULL
Mitjavila	NULL
,	NULL
M-T.	NULL
,	NULL
Casadevall	NULL
,	NULL
N.	NULL
,	NULL
Guichard	NULL
,	NULL
J.	NULL
,	NULL
Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
Miura	NULL
,	NULL
Y.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Breton-Gorius	NULL
,	NULL
J.	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
erythropoietin	NULL
act	NULL
competitively	NULL
to	NULL
induce	NULL
two	NULL
different	NULL
programs	NULL
of	NULL
differentiation	NULL
in	NULL
the	NULL
human	NULL
pluripotent	NULL
cell	NULL
line	NULL
UT-7	NULL
.	NULL

Blood	NULL
,	NULL
80	NULL
:	NULL
3060-3069	NULL
,	NULL
1992	NULL
.	NULL

23	NULL
.	NULL

Minegishi	NULL
,	NULL
N.	NULL
,	NULL
Minegishi	NULL
,	NULL
M.	NULL
,	NULL
Tsuchiya	NULL
,	NULL
S.	NULL
,	NULL
Fujie	NULL
,	NULL
H.	NULL
,	NULL
Nagai	NULL
,	NULL
T.	NULL
,	NULL
Hayashi	NULL
,	NULL
N.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Konno	NULL
,	NULL
T.	NULL
Erythropoietin-dependent	NULL
induction	NULL
of	NULL
hemoglobin	NULL
synthesis	NULL
in	NULL
a	NULL
cytokine-dependent	NULL
cell	NULL
line	NULL
M-TAT	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
:	NULL
27700-27704	NULL
,	NULL
1994	NULL
.	NULL

24	NULL
.	NULL

Goncalves	NULL
,	NULL
F.	NULL
,	NULL
Lacout	NULL
,	NULL
C.	NULL
,	NULL
Villeval	NULL
,	NULL
J-L.	NULL
,	NULL
Wendling	NULL
,	NULL
F.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Dumenil	NULL
,	NULL
D.	NULL
Thrombopoietin	NULL
does	NULL
not	NULL
induce	NULL
lineage-restricted	NULL
commitment	NULL
of	NULL
MpI-R	NULL
expressing	NULL
pluripotent	NULL
but	NULL
permits	NULL
their	NULL
complete	NULL
495	NULL
496	NULL
-	NULL
Thrombopoietin	NULL
and	NULL
Erythropoiesis	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
differentiation	NULL
.	NULL

Blood	NULL
,	NULL
89	NULL
:	NULL
3544-3553	NULL
,	NULL
1997	NULL
.	NULL

25	NULL
.	NULL

Lumeisky	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
and	NULL
Forget	NULL
,	NULL
B.	NULL
G.	NULL
Negative	NULL
regulation	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
during	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
a	NULL
human	NULL
erythroleukemic	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
:	NULL
3528-3536	NULL
,	NULL
1991	NULL
.	NULL

26	NULL
.	NULL

Iwatsuki	NULL
,	NULL
K.	NULL
,	NULL
Endo	NULL
,	NULL
T.	NULL
,	NULL
Misawa	NULL
,	NULL
H.	NULL
,	NULL
Yokouchi	NULL
,	NULL
M.	NULL
,	NULL
Matsumoto	NULL
,	NULL
A.	NULL
,	NULL
Ohtsubo	NULL
,	NULL
M.	NULL
,	NULL
Mori	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Yoshimura	NULL
,	NULL
A.	NULL
STATS	NULL
activation	NULL
correlates	NULL
with	NULL
erythropoietin	NULL
receptor-mediated	NULL
erythroid	NULL
differentiation	NULL
of	NULL
an	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
:	NULL
8149-8152	NULL
,	NULL
1997	NULL
.	NULL

27	NULL
.	NULL

Chretien	NULL
,	NULL
S.	NULL
,	NULL
Varlet	NULL
,	NULL
P.	NULL
,	NULL
Verdier	NULL
,	NULL
F.	NULL
,	NULL
Gobert	NULL
,	NULL
S.	NULL
,	NULL
Cartron	NULL
,	NULL
J-P.	NULL
,	NULL
Gisselbrecht	NULL
,	NULL
S.	NULL
,	NULL
Mayeux	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Lacombe	NULL
,	NULL
C.	NULL
Erythropoietin-induced	NULL
erythroid	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
TF-1	NULL
correlates	NULL
with	NULL
impaired	NULL
STATS	NULL
activation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
:	NULL
4174-4181	NULL
,	NULL
1996	NULL
.	NULL

28	NULL
.	NULL

Kirito	NULL
,	NULL
K.	NULL
,	NULL
Uchida	NULL
,	NULL
M.	NULL
,	NULL
Yamada	NULL
,	NULL
M.	NULL
,	NULL
Miura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Komatsu	NULL
,	NULL
N.	NULL
A	NULL
distinct	NULL
function	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
erythropoietin	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
:	NULL
16507-16513	NULL
,	NULL
1997	NULL
.	NULL

29	NULL
.	NULL

Matsumura	NULL
,	NULL
I.	NULL
,	NULL
Ishikawa	NULL
,	NULL
J.	NULL
,	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
Oritani	NULL
,	NULL
K.	NULL
,	NULL
Tomiyama	NULL
,	NULL
Y.	NULL
,	NULL
Miyagawa	NULL
,	NULL
J.	NULL
,	NULL
Kato	NULL
,	NULL
T.	NULL
,	NULL
Miyazaki	NULL
,	NULL
H.	NULL
,	NULL
Matsuzawa	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Kanakura	NULL
,	NULL
Y.	NULL
Thrombopoietin-induced	NULL
differentiation	NULL
of	NULL
a	NULL
human	NULL
megakaryoblastic	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
CMK	NULL
,	NULL
involves	NULL
transcriptional	NULL
activation	NULL
of	NULL
p21WA	NULL
``	NULL
!	NULL

``	NULL
0P	NULL
``	NULL
by	NULL
STATS	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
:	NULL
2933-2943	NULL
,	NULL
1997	NULL
.	NULL

30	NULL
.	NULL

Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Nakauchi	NULL
,	NULL
H.	NULL
,	NULL
Miwa	NULL
,	NULL
A.	NULL
,	NULL
Ishihara	NULL
,	NULL
T.	NULL
,	NULL
Eguchi	NULL
,	NULL
M.	NULL
,	NULL
Moroi	NULL
,	NULL
M.	NULL
,	NULL
Okada	NULL
,	NULL
M.	NULL
,	NULL
Sato	NULL
,	NULL
Y.	NULL
,	NULL
Wada	NULL
,	NULL
H.	NULL
,	NULL
Yawata	NULL
,	NULL
Y.	NULL
,	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
with	NULL
megakaryocytic	NULL
features	NULL
:	NULL
dependency	NULL
on	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
interleukin-3	NULL
,	NULL
or	NULL
erythropoietin	NULL
for	NULL
growth	NULL
and	NULL
sur-vival	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
517	NULL
:	NULL
341-348	NULL
,	NULL
1991	NULL
.	NULL

31	NULL
.	NULL

Fauser	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Messner	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Identification	NULL
of	NULL
megakaryocytes	NULL
,	NULL
macrophage	NULL
and	NULL
eosinophils	NULL
in	NULL
colonies	NULL
of	NULL
human	NULL
bone	NULL
marrow	NULL
contain	NULL
ing	NULL
neutrophilic	NULL
granulocytes	NULL
and	NULL
erythroblasts	NULL
.	NULL

Blood	NULL
,	NULL
53	NULL
:	NULL
1023-1027	NULL
,	NULL
1979	NULL
.	NULL

32	NULL
.	NULL

Mosmann	NULL
,	NULL
T.	NULL
Rapid	NULL
colorimetric	NULL
assay	NULL
for	NULL
cellular	NULL
growth	NULL
and	NULL
sur-vival	NULL
:	NULL
application	NULL
to	NULL
proliferation	NULL
and	NULL
cytotoxicity	NULL
assays	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
,	NULL
65	NULL
:	NULL
55-63	NULL
,	NULL
1983	NULL
.	NULL

33	NULL
.	NULL

Guimaraes	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Berney	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Francis	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Hoffbrand	NULL
,	NULL
A.	NULL
V.	NULL
The	NULL
identification	NULL
of	NULL
mixed	NULL
granulocytic-erythrocytic	NULL
colonies	NULL
in	NULL
vitro	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
535-538	NULL
,	NULL
1984	NULL
.	NULL

34	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Bio-chem	NULL
.	NULL

,	NULL
162	NULL
:	NULL
156-159	NULL
,	NULL
1987	NULL
.	NULL

35	NULL
.	NULL

Basset	NULL
,	NULL
P.	NULL
,	NULL
Beuzard	NULL
,	NULL
Y.	NULL
,	NULL
Garel	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Rosa	NULL
,	NULL
J.	NULL
Isoelectric	NULL
focusing	NULL
of	NULL
human	NULL
hemoglobin	NULL
:	NULL
its	NULL
application	NULL
to	NULL
screening	NULL
,	NULL
to	NULL
the	NULL
characterization	NULL
of	NULL
70	NULL
variants	NULL
,	NULL
and	NULL
to	NULL
the	NULL
study	NULL
of	NULL
modified	NULL
fractions	NULL
of	NULL
normal	NULL
hemoglo-bins	NULL
.	NULL

Blood	NULL
,	NULL
51	NULL
:	NULL
971-982	NULL
,	NULL
1978	NULL
.	NULL

36	NULL
.	NULL

Ponez	NULL
,	NULL
M.	NULL
,	NULL
Surrey	NULL
,	NULL
S.	NULL
,	NULL
LaRocco	NULL
,	NULL
P.	NULL
,	NULL
Weiss	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Rappaport	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Conway	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
Schwartz	NULL
,	NULL
E.	NULL
Cloning	NULL
and	NULL
characterization	NULL
of	NULL
platelet	NULL
factor	NULL
4	NULL
cDNA	NULL
derived	NULL
from	NULL
a	NULL
human	NULL
erythroleukemic	NULL
cell	NULL
line	NULL
.	NULL

Blood	NULL
,	NULL
69	NULL
:	NULL
219-223	NULL
,	NULL
1984	NULL
.	NULL

37	NULL
.	NULL

Imagawa	NULL
,	NULL
S.	NULL
,	NULL
Izumi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
erythropoietin	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
:	NULL
9038-9044	NULL
,	NULL
1994	NULL
.	NULL

38	NULL
.	NULL

Ponte	NULL
,	NULL
P.	NULL
,	NULL
Ng	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
,	NULL
Gunning	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Kedes	NULL
,	NULL
L.	NULL
Evolutionary	NULL
conservation	NULL
in	NULL
the	NULL
untranslated	NULL
regions	NULL
of	NULL
actin	NULL
mRNAs	NULL
:	NULL
DNA	NULL
sequence	NULL
of	NULL
a	NULL
human	NULL
B-actin	NULL
mRNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
12	NULL
:	NULL
1687-1696	NULL
,	NULL
1984	NULL
.	NULL

39	NULL
.	NULL

Shinjo	NULL
,	NULL
K.	NULL
,	NULL
Takeshita	NULL
,	NULL
A.	NULL
,	NULL
Ohnishi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ohno	NULL
,	NULL
R.	NULL
Expression	NULL
of	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
increases	NULL
with	NULL
differentiation	NULL
in	NULL
myeloid	NULL
cells	NULL
by	NULL
a	NULL
newly-devised	NULL
quantitative	NULL
flow-cytometric	NULL
assay	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Haematol	NULL
.	NULL

,	NULL
91	NULL
:	NULL
783-794	NULL
,	NULL
1995	NULL
.	NULL

